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Abstract
The cattle industry worldwide is greatly impacted by bovine respiratory disease (BRD), a
bacterial disease caused by Mannheimia haemolytica. Recent efforts to design vaccines against
M. haemolytica focus on a virulence factor, leukotoxin, in addition to surface lipoproteins. Plantbased protein production is a safe and inexpensive alternative to traditional methods. Edible
vaccines deliver antigens to pharyngeal tissues, which can provide local immunization against
M. haemolytica prior to its progression into the lungs. In this project, a chimeric protein
containing M. haemolytica antigens was produced in tobacco chloroplasts as a candidate edible
vaccine for BRD. Attempts were made to transform lettuce chloroplasts as an alternative
production platform, including extensive genetic and procedural modifications. This endeavor
necessitated the optimization of lettuce growth, regeneration and transformation and will thereby
support future work with transplastomic lettuce.
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Introduction
1.1

M. haemolytica and bovine respiratory disease

Ruminants such as cattle rely heavily on a diverse community of bacterial endosymbionts
for digestion and other processes (Halliwell, 1957; Hungate, 1966). However, cattle also
face a vast array of infectious bacteria, a challenge greatly worsened by modern farming
practices. One of the most dangerous is Mannheimia haemolytica, which colonizes the
upper respiratory tract of ruminants (Carter et al., 1995; Frank, 1989). While some strains
of M. haemolytica reside within the upper respiratory tract unnoticed, others
opportunistically infect the lungs of immunocompromised calves, particularly during
shipping of calves from farms to feedlots. This has earned the resulting illness the
appropriate names “shipping fever” and “bovine respiratory disease” (BRD) (Rice et al.,
2007; Yates, 1982). Cattle suffering from BRD exhibit devastating symptoms: lobar
pneumonia deep within the lungs, accompanied by lung exudates containing immune
cells and the clotting protein fibrin (Allan, 1978; Hoerlein et al., 1961; Schiefer et al.,
1978; Thomson et al., 1975; Yates, 1982). These exudates cause pleural inflammation
that exerts pressure upon the lungs, greatly hindering respiration (Rice et al., 2007; Yates,
1982). The economic impact of BRD is large, as symptoms can often lead to death. A
2010 survey of the United States cattle industry found that 26.5% of all non-predatorrelated deaths, a total of 460 000 cattle, resulted from BRD (USDA, 2011a). Not
surprisingly, BRD is the most common and costly disease in North American feedlot
cattle (Smith, 1998). Economic losses as a result of BRD in North American feedlots
have been approximated at $500 million (Miles, 2009) to $1 billion per year (Whiteley et
al., 1992).
Efforts to combat infection by M. haemolytica often employ antibiotics, which are
expensive and applied non-specifically at high dosages (Rice et al., 2007; Zecchinon et
al., 2005). This practice has produced antibiotic-resistant strains of M. haemolytica,
(Highlander, 2001; Kehrenberg et al., 2001) with over 40% of strains in some areas
resistant to five antibiotics (Hörmansdorfer et al., 1996). Physical interventions such as
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isolation of infected calves are difficult, as diagnostic tests are labour-intensive,
expensive (Fulton et al., 2012) or not sensitive enough to detect infected calves
(McCorkell et al., 2014).
M. haemolytica, previously known as Pasteurella haemolytica, are non-motile, gramnegative, coccobacilli (Hirsch et al., 1999; Quinn, 1994) that primarily inhabit the
nasopharynx and tonsils of ruminants (Babiuk et al., 1984; Frank et al., 1992; 1995). Of
the 12 M. haemolytica serotypes, the majority of BRD cases are associated with serotypes
A1 (Allan et al., 1985; Frank et al., 1983a) and A6 (Al-Ghamdi et al., 2000; Ewers et al.,
2004). Not unexpectedly, the A1 and A6 serotypes possess highly similar surface
molecules (Davies et al., 1996; Morton et al., 1996). Affecting approximately 16% of
feedlot cattle in the United States in 2011 (USDA, 2011b), the A1 M. haemolytica
serotype is the predominant cause of BRD (Allan, 1978; Frank et al., 1983b; Whiteley et
al., 1992). Consequently, efforts to understand and prevent this illness have been strongly
directed towards serotype A1 (Brogden et al., 1995; Conlon et al., 1993; Gatewood et al.,
1994; Lee et al., 2001; 2003; Lo et al., 1985; 1987).
M. haemolytica accomplish strong virulence primarily through exploitation of vulnerable
calves. During the shipping process, calves face immune suppression due to physical
factors including cold-stress (Slocombe et al., 1984) and transportation-associated stress
(Aich et al., 2009; Filion et al., 1984; Jericho, 1979). As they enter feedlots, calves from
multiple farms are mixed (Ribble et al., 1995) and are thereby introduced to a battery of
viruses and bacteria (Rice et al., 2007) that contribute to the suppression of innate
immunity by altering calf mucous secretions, anionic peptides and β-defensins (Brogden
et al., 1998). While many calves are exposed to some strain of M. haemolytica prior to
shipping, it is during the shipping process that virulent strains, particularly A1, spread to
vulnerable calves. Unfortunately, prior exposure to less-aggressive strains such as A2
does not confer protection against the A1 strain (Purdy et al., 1998). Healthy calves can
effectively expel M. haemolytica from the lungs: in four hours (hr), 90% of administered
bacteria can be removed (Lillie et al., 1972). However, infection by synergistic viruses
impedes this process: bovine viral diarrhea virus, parainfluenza virus 3 (PI-3), and bovine
herpes virus 1 inhibit ciliary activity of tracheal epithelial cells (Rossi et al., 1977). PI-3
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also has been demonstrated to inhibit pulmonary expulsion of M. haemolytica in calves
(Lopez et al., 1976).
In addition to their exploitative nature, the strong pathogenicity of M. haemolytica is
thought to be owed to a virulence factor named leukotoxin (Lkt). Lkt is produced by
M. haemolytica during lag- and log-phase growth, likely following progression into the
uncolonized lower respiratory tract (Shewen et al., 1985). Lkt ultimately causes lysis of
leukocytes and platelets (Atapattu et al., 2005; Baluyut et al., 1981; Clinkenbeard et al.,
1989b; 1991). Lkt is a part of the repeats-in-toxin (RTX) family of cytotoxins,
specifically the pore-forming RTX toxins, and is closely related to the α-haemolysin of
Escherichia coli (Davies et al., 2001; Lo, 1990; Strathdee et al., 1987). Lkt has
detrimental effects on macrophages and other leukocytes, but has more severe effects on
neutrophils (Clarke et al., 1998; Clinkenbeard et al., 1989a, 1989b; O'Brien et al., 1987).
Macrophages from young calves are more susceptible to Lkt than those of adult cattle
(O'Brien et al., 1987). The result of Lkt exposure in bovine leukocytes is dose-dependent.
At low concentrations, Lkt initiates neutrophil degranulation, followed by the generation
of free radical molecules, and release of cytokines (Singh et al., 2011), leading to
inflammation (Czuprynski et al., 1991; Maheswaran et al., 1992; Zecchinon et al., 2005).
At relatively moderate concentrations, Lkt promotes apoptosis of leukocytes (Lally et al.,
1999; Stevens et al., 1996; Sun et al., 1999). At even higher concentrations, Lkt causes
the lysis of neutrophils via pore-formation within neutrophil plasma membranes (Clarke
et al., 1998; Clinkenbeard et al., 1989a, 1989b). The mechanism of Lkt activity has been
thoroughly-studied. A nonapeptide repeat on the C-terminus of Lkt (Coote, 1992) binds
to CD18, a component of the lymphocyte function associated-1 (LFA-1) receptor on the
surface of bovine leukocytes (Arnaout, 1990; Jeyaseelan et al., 2000; Li et al., 1999;
Mentzer et al., 1987). The LFA-1 receptor is an integrin molecule involved in activation
of the cell-stress caspase-9-dependent apoptosis pathway (Atapattu et al., 2005). This
initiates a signal cascade involving G proteins that causes the opening of voltage-gated
calcium channels, leading to a dose-dependent elevation of intracellular calcium
concentration (Gerbig et al., 1989; Hsuan et al., 1998; 1999; Jeyaseelan et al., 2001a;
2001b; Ortiz‐Carranza et al., 1992). This influx of calcium from the extracellular fluid
leads to apoptosis via the NF-KB pathway, cytolysis (Gerbig et al., 1989), and the
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production of pro-inflammatory cytokines including IL-8, IL-1β and, TNF-α (Hsuan et
al., 1999; Sang-Yoo et al., 1995). Together, these responses lead to mobilization of
neutrophils, exacerbation of inflammation, and continually worsening symptoms of
M. haemolytica infection (Slocombe et al., 1985; Weiss et al., 1991).
To avoid antibiotic overuse, an attractive preventative strategy against M. haemolytica
infection is vaccination. The first vaccines against BRD were created over 100 years ago,
and comprised killed or attenuated M. haemolytica cultures (bacterins) (Mosier et al.,
1989). Unfortunately, these vaccines have either proved detrimental (Farley, 1932), or
did not show any protective benefit (Mosier et al., 1989). Despite continued development,
more recent bacterin-based M. haemolytica vaccines appear to be either ineffective
(Hamdy et al., 1965; Martin, 1983), or harmful to calves (Friend et al., 1977; Highlander
et al., 2000; Schipper et al., 1971; Wilkie et al., 1980). Similarly, vaccines comprising
live bacteria are not consistently protective (Mosier et al., 1998; Purdy et al., 1986; Smith
et al., 1985), and are unamenable to usage in feedlots, where antibiotics are prevalent
(Hjerpe, 1990; Rice et al., 2007; Zecchinon et al., 2005). Another type of commercially
available vaccine is formulated from supernatants of log-phase M. haemolytica cell
cultures, shown by ELISA (Enzyme-linked immunosorbent assay) and agglutination
assays to contain secreted Lkt and cell surface molecules including capsular
polysaccharide and iron regulated outer membrane proteins (Shewen et al., 1985; Srinand
et al., 1996). One commercial vaccine, Presponse, has some efficacy, reducing
pneumonic tissue by 56% in one experimental trial (Conlon et al., 1995), and initiating
antibody responses against Lkt and capsular polysaccharide (Srinand et al., 1996).
However, the results of field trials conducted using this vaccine were inconsistent
(Bateman, 1988; Jim et al., 1988), with one study of 1192 calves revealing no
distinguishable difference between vaccinated and unvaccinated calves (Thorlakson et
al., 1990). Supplementation of cell culture supernatant vaccines with recombinant Lkt led
to improved clinical scores following experimental challenge with M. haemolytica.
However, it is notable that administering Lkt alone does not appear to provide any
detectable level of protection against M. haemolytica (Conlon et al., 1991a).
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The relative success of protein-based cell-free vaccines has led to the development of
M. haemolytica protein subunit vaccines, which comprise partial antigens, intended to
elicit specific antibody responses. Subunit vaccine design has been guided by knowledge
of molecular interactions between M. haemolytica proteins and the host immune system.
Effective host defense functions primarily through two mechanisms: neutralization of
active Lkt (Pandher et al., 1999), and destruction of M. haemolytica by immune cells
through agglutination, complement-mediated killing, and phagocytosis (Czuprynski et al.,
1987; MacDonald et al., 1983; Pandher et al., 1998). These activities are supported by
host antibody binding to both M. haemolytica cell surfaces and secreted Lkt (Confer et
al., 1985; Pandher et al., 1998). Antibodies capable of neutralizing Lkt activity have been
revealed to bind to an epitope near the C-terminus, within a region known as nLkt
(Lainson et al., 1996; Rajeev et al., 2001). A well-studied M. haemolytica surface
lipoprotein, Pasteurella lipoprotein E (plpE), has been demonstrated to provide
protection as a vaccine against M. haemolytica (Confer et al., 2003; 2006). The most
highly antigenic epitope of PlpE has been mapped to a region near the N-terminus, R2,
which comprises eight non-identical hexapeptide repeats (Ayalew et al., 2004). Cattle
administered a portion of PlpE containing the R2 region (rPlpE) in addition to the
commercial Presponse vaccine were significantly more resistant to M. haemolytica A1
and A6 infection than those administered Presponse alone (Confer et al., 2003; 2006).
Using this knowledge, vaccines composed of nLkt and rPlpE have been designed and
tested experimentally (Ayalew et al., 2008). These tests demonstrated the production of
antibodies that neutralized Lkt, as well as those that bound PlpE to facilitate complementmediated bacteriolysis and phagocytosis (Ayalew et al., 2008). This vaccine, composed
of two copies of each rPlpE and nLkt, in tandem as nLkt-rPlpE-nLkt-rPlpE, improved
calf resistance against M. haemolytica infection, reducing pleural lesion scores by 75%
when co-administered with a bacterin, or by 35% when administered alone (Confer et al.,
2009a). For comparison, lesion scores were reduced by 36% when bacterins were
administered alone, suggesting that protective effects may be additive.
Attempts to optimally administer protein-subunit vaccines have been directed by
knowledge of specific host-pathogen interactions. As commensal bacteria,
5

M. haemolytica initially colonize the tonsillar and nasal mucosae (Babiuk et al., 1984)
before progressing to the lungs where they cause damage leading to the symptoms of
BRD (Grey et al., 1971). Current commercially available vaccines aim to prepare calf
immune systems to combat M. haemolytica infection once it has reached the lungs. This
is accomplished via induction of systemic immunity against M. haemolytica through
subcutaneous or intramuscular parenteral administration of the vaccine (Confer et al.,
2003; 2006; Thorlakson et al., 1990; Tucci et al., 2016). Internal injection of vaccines
leads to the induction of a pro-inflammatory response throughout the body, ultimately
causing the generation of IgG antibodies, which circulate in the blood and extracellular
space (Junqueira, 2003; Schur, 1987). Alternatively, recently developed vaccines aim to
prepare calf immune systems to neutralize M. haemolytica bacteria prior to their entry
into the lungs through induction of mucosal immunity. Mucosal immunity is triggered by
the recognition of potentially harmful antigens by the mucosa-associated lymphoid tissue,
which ultimately leads to the production of secretory IgA antibodies (sIgA), secreted into
the mucous. As M. haemolytica infection occurs following its progression past mucosal
surfaces, mucosal immunization against this bacterium is particularly attractive.
In hopes of inducing mucosal immunity, many recombinant vaccines in development are
intended for nasal or oral delivery (Ayalew et al., 2009; Confer et al., 2009a; 2009b; Lee
et al., 2001; 2003; 2008). Although mucosal immunization is particularly advantageous
for generation of sIgA antibodies, this method can also induce systemic immune
responses (Garulli et al., 2004; Staats et al., 1994). IgG antibodies against both Lkt and
PlpE were generated in calves following nasal (mucosal) administration of the
aforementioned nLkt-rPlpE-nLkt-rPlpE vaccine (Confer et al., 2009b).
Induction of mucosal immunity can be enhanced by coupling antigens to the B-subunit of
the cholera toxin (CTB), improving antigen reception by dendritic cells and macrophages
(Holmgren et al., 2005). CTB binds to the mammalian cell surface receptor GM1
ganglioside, found on mucosal cells of the upper respiratory tract and intestines,
triggering uptake of CTB (de Haan et al., 1998; Spangler, 1992) along with any coupled
molecules present (Holmgren et al., 2005). Additionally, CTB functions as an adjuvant
due to a strong immunogenic effect in mucosal tissues, triggering an immune response
6

and promoting the development of antibodies against co-administered antigens.
Expectedly, CTB has been incorporated into many vaccines administered either orally or
nasally (Davoodi-Semiromi et al., 2010; Hamorsky et al., 2013; Holmgren et al., 2005;
Lee et al., 2014; Ruhlman et al., 2007; Sheoran et al., 2002). Nasal administration of a
recombinant vaccine against M. haemolytica in combination with CTB as a protein
adjuvant led to the generation of nasal anti-Lkt and anti-PlpE antibodies (Confer et al.,
2009b). Another vaccine developed by the same group consisted of Lkt and PlpE
covalently linked to CTB, rather than supplementing the vaccine with the CTB protein
(Ayalew et al., 2009). This vaccine was tested alongside the group’s previously-designed
vaccines: nLkt-rPlpE-nLkt-rPlpE alone and supplemented with CTB, and calves were
vaccinated then challenged with M. haemolytica. This experiment revealed that the two
vaccines containing CTB offered the most protection against the bacteria, resulting in
better clinical scores for calves receiving those vaccines. Additionally, the CTB-linked
vaccine produced the highest level of anti-PlpE antibodies in serum, suggesting that
CTB-linkage could provide systemic benefits as well (Ayalew et al., 2009).
While recombinant vaccines are a promising option, inefficiencies in production can
make them expensive and inaccessible to farmers (Daniell et al., 2009). Recombinant
vaccines require extensive processing prior to delivery. This includes purification,
formulation with adjuvants, and injection (Davoodi-Semiromi et al., 2010), which must
be performed under cold and sterile conditions (Daniell et al., 2009; Lee et al., 2008).
Processing of pharmaceutical proteins by current production methods through bacterial,
mammalian, or insect cell cultures accounts for up to 80% of productions costs (Chen,
2011). Conversely, plants require much simpler growth conditions and do not require
management of risks such as potential human pathogens, which do not infect plants. In
addition, plant tissues can be fed directly to recipients, eliminating the need for
purification. These benefits together can reduce total production and purification costs by
90% (Daniell et al., 2005). Foreign proteins can also be safely stored or shipped within
dried plant tissue at room temperature under non-sterile conditions following drying
(Boyhan et al., 2011; Lee et al., 2003). Lkt specifically has been demonstrated to be
stable in plant cells for at least one year after oven-drying (Lee et al., 2003). In addition
to being edible, plant cells are also amenable to oral delivery for their cell walls, which
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can protect recombinant antigens from stomach acids and enzymes that may otherwise
quickly degrade them (Kwon et al., 2013). The efficacy of plant-based orally-delivered
vaccines targeting the respiratory mucosa has been demonstrated by oral-administration
of plant-produced avian influenza haemagglutinin, which triggered the production of
sIgA in pleural secretions of mice, conferring protection against challenge with influenza
virus (Lee et al., 2015). In ruminants such as cattle, cellulosic cell walls are degraded
gradually through rumination, a process involving regurgitation, which facilitates
repeated exposure of tonsillar lymphoid tissue of the pharynx to released antigens (Lee et
al., 2003; 2008; Shewen et al., 2009). Exposure of the tonsils to M. haemolytica triggers
antibody responses in the nasal mucosa (Frank et al., 1992), and similarly tonsillar
exposure to M. haemolytica through feeding effectively prevents colonization (Briggs et
al., 1999; 2012), making the tonsils a prime target for local immunization through edible
vaccines.

1.2

Using plants to produce recombinant proteins

The ability to produce foreign proteins within plants is a relatively recent advancement
regarding plant genetic modification (GM). The vast majority of plant GMs thus far have
been conducted through selective breeding, and focused on the enhancement of nutrition,
stress tolerance, growth rates, and amenability to use as crops. Recently, owing to
advancements in the knowledge and tools of molecular biology, plant GM has become
much faster. In 1983, the first GM plants were created: sunflower and tobacco,
transformed with a bean phaseolin gene (Murai et al., 1983) and bacterial antibioticresistance genes (De Block et al., 1984; Horsch et al., 1984), respectively. The ability to
produce foreign proteins in plants for human use was later realized and exploited, as the
first pharmaceutical protein, human growth hormone (hGH), was produced in plants
(Barta et al., 1986). Successful production of hGH among other proteins such as a
functional mouse IgG (Hiatt et al., 1989) encouraged further developments by scientists
attempting to produce valuable pharmaceuticals in plants. The field has since grown
tremendously, and been given the name “molecular farming” as scientists endeavour to
farm pharmaceutical and other biologically-active molecules (Xu et al., 2012).
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Transformation of plants was first, and is still conducted using the bacterium
Agrobacterium tumefaciens. A. tumefaciens naturally transfers tumour-inducing genes to
plant cells, ultimately causing crown-gall disease (Chilton et al., 1977). These tumourinducing genes are located upon a tumour-inducing (Ti) plasmid within the transfer DNA
(T-DNA), flanked by left and right border sequences that facilitate T-DNA excision.
Virulence proteins enable T-DNA transfer to the plant cell nucleus, where it integrates
into the nuclear genome and is expressed by the host cell (Gelvin, 2003). With
knowledge of this process, scientists adapted the natural genetic engineer for human use,
creating new versions of the Ti plasmid capable of receiving foreign genes for rapid
delivery to plant cells (Krenek et al., 2015). Further exploration of the A. tumefaciens
transformation system revealed that transgene expression exhibits temporal variation.
Plant cell nuclear expression rises two to four days post-infection, drops significantly,
and rises once more roughly 14 days post-infection (Janssen et al., 1990). This
phenomenon has since been explained: many T-DNA copies are delivered to the host cell
nucleus and expressed but do not integrate within the genome. These copies are
transiently-expressed to produce the initial expression peak, but are degraded thereafter
(Janssen et al., 1990). Some copies of the T-DNA stably insert into the genome over
time, and expression of these copies leads to a later rise at roughly 14 days, continuing
thereafter due to insertion stability (Janssen et al., 1990). Scientists have made use of
both of these expression peaks following A. tumefaciens-mediated transformation for the
production of foreign proteins in plants (Ahmad et al., 2010; Daniell et al., 2009).
To generate stably-transformed plants requires regeneration while applying selection for
transgene insertion (Gelvin, 2003). However, it is also necessary to screen for single
insertion of the transgene within the genome, otherwise transgene silencing may act to
abrogate foreign protein production entirely (Gelvin, 2003; Rajeev et al., 2015).
Following this, plants must be self-fertilized, and offspring screened to ensure
homozygosity (Visser et al., 1989). These necessary processes together make the
procedure of generating stable, nuclear-transformed plants long and labour-intensive
(Fischer et al., 2004). While stable nuclear transformation is useful for many studies, the
technique is inefficient with regard to protein accumulation, as low levels of protein can
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accumulate in these plants compared to those produced by other methods (Schillberg et
al., 2003; Wroblewski et al., 2005).
Another method of producing recombinant proteins is through transient expression of
DNA, thus avoiding silencing associated with multiple transgene insertions. Transientlyexpressed DNA is present in many copies, and therefore high levels of mRNA expression
and protein accumulation can be achieved (Daniell et al., 2009). Transient expression is
also relatively simple and fast to conduct: plants are grown to near maturity, then
“agroinfiltrated”: infiltrated (injected) with Agrobacterium carrying an expression
construct with a gene of interest (GOI) using a syringe or vacuum (Menassa et al., 2012).
Plants are then grown for several days while accumulating the protein product. Transient
expression has been conducted in many different plants (Sohi et al., 2005; Wroblewski et
al., 2005; Yasmin et al., 2010; Zottini et al., 2008), although the most amenable of these
is the close tobacco relative, Nicotiana benthamiana (Menassa et al., 2012).
N. benthamiana has a short life cycle, small size, and is easily agroinfiltrated using either
syringe or vacuum (Conley et al., 2011). Using N. benthamiana, several biotechnology
companies have been able to industrialize the agroinfiltration process, moving from
handheld syringe infiltration to large-scale automated vacuum infiltration (Fischer et al.,
2004). This has allowed the efficient production of large quantities of pharmaceuticals
and biologicals and is a continuously expanding industry.
Another attractive method of producing recombinant proteins in plants is through
transformation of the chloroplast genome. Chloroplasts were first transformed with nonplant genes in 1988 using particle bombardment (Boynton et al., 1988). In this method,
also known as biolistic (biological, ballistic) transformation, DNA is coated onto micro
particles and bombarded into plant tissue, reaching nuclear and organelle genomes
(Sanford, 2000). Particle bombardment has since been widely adopted as the method of
choice for chloroplast transformation, enabling scientists to conduct this process that
would otherwise be prohibitively cumbersome (Daniell et al., 2002; Maliga, 2002).
Impressively, the highest accumulation level of foreign protein in a plant, 70% of total
soluble protein (TSP), was accomplished through chloroplast transformation of tobacco

10

with the gene encoding protein antibiotic (Oey et al., 2009). High accumulation levels of
this antibiotic protein among other proteins are owed to several factors, including the
prokaryotic translational machinery of the chloroplast (Sugiura et al., 1998), an
endosymbiotic organelle of prokaryotic origin (Gray, 1993), the lack of silencing
mechanisms (Fischer et al., 2004), and the high ploidy of the chloroplast genome (Daniell
et al., 2009). To add to this, most plants have a high number of chloroplasts per cell, and
the chloroplast genome contains only roughly 130 genes (Bock, 2014b). Therefore, genes
inserted into the chloroplast are well-represented within the total genome and are
expressed at high levels. These inserted genes can also be easily directed to any locus in
the chloroplast genome, as transformation occurs by homologous recombination (Bock,
2014b). Owing to their cyanobacterial origin, chloroplasts contain genes arranged in
operons, allowing transgenes to be inserted in sequence for co-expression from the same
promoter (Bock, 2015). Chloroplast transformation also offers biocontainment of
transgenes. In the vast majority of angiosperm species, chloroplasts are maternally
inherited and are not present in pollen, and therefore the potential for outcrossing with
native plants or nearby crops is significantly diminished (Bock, 2014b; Daniell, 2007).
One of the first successfully transformed plants, tobacco is the most popular and well
established model plants for transgene expression (Fischer et al., 2004). Likely owing to
tobacco’s popularity as a model plant, foreign proteins have thus-far been produced to the
highest levels of all plants in tobacco (Oey et al., 2009). Tobacco is also attractive for its
high biomass and relatively fast growth, which provide scalability for industrial
production (Fischer et al., 2004). Since tobacco is not used for human food or animal
feed, there is decreased risk of transgenic material entering food supplies (Stoger et al.,
2002). However, tobacco is high in toxic alkaloids such as nicotine, which can prove
harmful to consumers and can therefore hamper edible vaccine-development (DavoodiSemiromi et al., 2010). To overcome this hindrance, some scientists have begun using
low-alkaloid tobacco cultivars (Gutiérrez et al., 2013; Kenward et al., 1999; Kolotilin et
al., 2013; Menassa et al., 2007), and alternative production platforms such as alfalfa,
lettuce and tomato were developed (D’Aoust et al., 2004; Dong et al., 2014; Kanagaraj et
al., 2011; Su et al., 2015; Wroblewski et al., 2005).
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One edible plant currently gaining attention as an alternative production platform is
lettuce. Lettuce is capable of yielding high biomass in a relatively short time, roughly six
weeks after planting (Davoodi-Semiromi et al., 2010; Mackowiak et al., 1994; Su et al.,
2015), and produces few alkaloids or phenolic compounds (Lai et al., 2012). Lettuce also
has generally regarded as safe status (GRAS) under the United States Food and Drug
Administration, and can be cultivated throughout all seasons in greenhouses, with
existing systems permitting safe large-scale production and distribution (Lai et al., 2012).
Bio-containment beyond that offered by greenhouse growth and chloroplast
transformation is provided by late-flowering of lettuce (Daniell, 2002; Weaver, 1997).
Both transient expression by agroinfiltration (Wroblewski et al., 2005) and chloroplast
transformation by particle bombardment (Kanamoto et al., 2006) have been adapted for
use in lettuce. It has been determined that lettuce chloroplasts are capable of
accumulating high levels of foreign proteins, with one group achieving 36% TSP
(Kanamoto et al., 2006) and another up to 53% of total leaf protein (TLP) (Boyhan et al.,
2011). Lettuce’s safety for growth and consumption, in combination with foreign proteinproduction capabilities make it a strong candidate for the production of recombinant
vaccines.
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1.3

Hypothesis and Objectives

In this project, I endeavored to produce an edible recombinant vaccine against
M. haemolytica in lettuce and tobacco, through both transient expression and chloroplast
transformation. In doing so, I hypothesize that a vaccine against M. haemolytica with
evidence of efficacy can be produced to appreciable levels in lettuce and tobacco. The
objectives of this study were:
1. Optimization of lettuce regeneration, transformation, and growth in the lab.
2. Design and assembly of genetic constructs for lettuce chloroplast transformation
and vaccine expression.
3. Transient expression of constructs in lettuce and N. benthamiana and assessment
of subcellular localization of proteins expressed in lettuce.
4. Transformation of lettuce and tobacco chloroplasts to produce a subunit vaccine
for BRD.
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Methods and Materials
2.1
2.1.1
2.1.1.1

L. sativa growth, regeneration, and analysis
L. sativa growth using multiple fertilizers and environments
L. sativa growth conditions

Seeds of 4 lettuce cultivars were purchased from Canadian suppliers: Simpson Elite
(Lindenberg Seeds Ltd.), Iceberg (Lindenberg Seeds Ltd.), Romaine (Lindenberg Seeds
Ltd.), Rouge d’hiver (West Coast Seeds). Plants were grown from seeds in Pro-Mix BX
soil (Premier Tech) in a growth room, growth chamber, or greenhouse. Growth
experiments were conducted on Simpson Elite lettuce only. The growth room and growth
chamber were set to a temperature of 22°C during a 16 hr light period and 18°C during an
8 hr dark period, 55% relative humidity. In the growth room, light intensity averaged 100
E. The greenhouse was set to a 16 hr light/8 hr dark cycle, with day time temperature of
25°C and night time temperature of 18°C. The greenhouse control system senses and
augments incoming light to provide 100 mM of light per day, at 55% relative humidity.
In the growth room and greenhouse, three different fertilizers were applied, with
percentage by weight of nitrogen-phosphorus-potassium of: 20-20-20 Classic (PlantProd, Brampton, ON), 20-8-20 Forestry Special (Plant-Prod), or Plant-Prod Solutions 198-13 Total Plus. Fertilizer type and concentration were adjusted as independent variables.
In the growth chamber, plants were watered exclusively with 1 g/L 20-20-20 fertilizer,
and light intensity was altered as an independent variable. Plants were consistently
harvested 7 weeks after seeding, and above-ground tissue was removed, weighed and
recorded. Above-ground tissue was then frozen at -80°C for a minimum of 16 hr, then
lyophilized using a FreeZone 18 Liter Console Freeze Dry System (Labconco, Kansas
City, USA). Lyophilized tissue was weighed once more to determine the dry weight
(DW) of each plant.
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2.1.1.2

L. sativa characteristic analysis

At the time of harvest, three samples consisting of three leaf discs each were collected
from leaves of differing ages from each plant using a 7 mm cork borer. Each sample was
weighed using a Sartorius (Göttingen, Germany) B 120S fine balance, placed in 2 mL
tubes with three, 2.3 mm ceramic beads, and flash frozen in liquid nitrogen and stored at 80°C. To determine total soluble protein (TSP), proteins were extracted from each sample
and Bradford assays (Bradford, 1976) were conducted. Briefly, to extract proteins, frozen
leaf discs were homogenized for two intervals of one minute (min) each using a
TissueLyser (Qiagen, Venlo, Netherlands). Samples were then centrifuged at 3000 x g for
one min and 200 μL of plant protein extraction buffer was added to each sample. This
protein extraction buffer consists of 1X PBS, 2% (w/v) polyvinylpolypyrrolidone
(PVPP), 0.1% (v/v) Tween-20, 100 mM ascorbic acid, 1 mM of phenylmethanesulfonyl
fluoride (PMSF), 1 mM ethylenediaminetetraacetic acid (EDTA), and 1 μg/mL leupeptin.
Tubes were vortexed for five seconds (sec) both upright and inverted, then centrifuged at
4°C for 10 min at 20,817 x g. Two microliters of supernatant was collected from each
tube and used in a Bradford assay, as described in section 2.1.1.2. Protein concentration
was determined using a Bio-Rad iMark™ Microplate Reader.
Differences between above-ground fresh weights (FW), DW, and total soluble protein
content per DW or FW of plants treated differently were compared via statistical analysis.
Comparisons between groups were conducted using a one-way analysis of variance
(ANOVA), and a Levene’s test was used to determine whether treatment groups had
equal variances. Following determination of statistical significance via ANOVA,
differences between groups with equal variances were compared using a Tukey Pairwise
Comparison. Differences between groups with unequal variances were compared by a
Games-Howell Pairwise Comparison. All statistical analyses were conducted using the
Statistical Software Package for Social Sciences (SPSS) (IBM, North Castle, New York,
USA).
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2.1.2

Assay of protein content in L. sativa cultivars,
N. benthamiana and N. tabacum

L. sativa plants of each of the 4 cultivars were grown from seeds as described (2.1.1.1)
for growth experiments, and watered daily with 1.5 g/L of 20-20-20 fertilizer. At age 49
days, lettuce plants were harvested as described in section 2.1.1.1. N. benthamiana plants
were grown for 49 days and watered with 0.5 g/L 20-8-20 fertilizer prior to
sampling. N. tabacum were grown from regenerated calli, and sampled approximately
five weeks after transfer to soil. Bradford assays (described in section 2.1.1.2) were
conducted to determine the TSP content of all plants.

2.1.3

L. sativa flowering

L. sativa plants of each of the 4 cultivars were grown in the greenhouse from seeds as
described in section 2.1.1.1, and watered daily with 1 g/L of 20-20-20 fertilizer. Plants
were inspected twice weekly until flowers and seeds were observed. Plants were grouped
according to cultivar, and the average age of each cultivar at its time of flowering and
producing seeds was compared as described in section 2.1.1.2.

2.1.4

L. sativa regeneration

L. sativa seeds of all four cultivars: Simpson Elite, Rouge d’hiver, Iceberg, and Romaine
were sterilized and grown in the same manner. Seeds were wrapped in pouches formed
from folded and tied KimWipes, immersed in 70% (v/v) ethanol for 30 sec, immersed in
sterile, filtered, deionized MilliQ (Merck Millipore, Darmstadt, Germany) water for 30
sec, then immersed in a 10% bleach (0.525% sodium hypochlorite), 0.2% Tween-20
solution, followed by three additional washes in sterile MilliQ water. Sterile seeds were
grown in sterile Millipore-Sigma Phytatray™ containers on sterile basal media, (4.43 g/L
Murashige & Skoog Basal Medium with vitamins, 30 g/L sucrose, 7 g/L agar, and
500 mg/L polyvinylpyrrolidone). Seeds were grown in a Conviron® (Winnipeg, Canada)
TC16 growth cabinet at 22°C with 16 hr light and 8 hr dark conditions for six weeks or
until fully expanded leaves, approximately 4 cm2 in size, appeared.
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Fully expanded leaves of 28 day-old plants were divided into 0.5 cm2 pieces and spread
onto deep-dish petri dishes containing L. sativa regeneration media composed of basal
media with added synthetic plant hormones: 6-benzylaminopurine (BAP) and
naphthaleneacetic acid (NAA). The concentration of NAA varied from 0.05 mg/L to
0.2 mg/L, while the concentration of BAP varied from 0.1 mg/L to 0.4 mg/L. Explants
were divided such that 12 explants were placed on each dish. Regenerating explants were
monitored weekly for new shoots, and the number of shoots present on each plate was
recorded each week. For each cultivar, regenerability under each hormone combination
was compared. Also, each cultivar’s most efficient regeneration in any medium was
compared to that of each other cultivar statistically, as described in section 2.1.1.2.

2.2
2.2.1

Transformation vector synthesis and cloning
Gene synthesis

The BRD candidate vaccine gene to be expressed was designed using information
gleaned from published studies and was composed of subunits of three genes: CTB, PlpE,
and Lkt (Ayalew et al., 2008; 2009; Confer et al., 2006; 2009a; 2009b), and was named
CPL, as it will be referred to hereinafter. The sequences of each gene correspond to
serotype A1, and were retrieved from the National Center for Biotechnology Information
(NCBI) database using accession numbers: ABQ65166 (CTB), ABB20693.1 (PlpE),
M20730 (Lkt). DNA sequences encoding each subunit were submitted to BioBasic
(Markham, Ontario) and were designed to be easily assembled using GoldenGate cloning
(Engler et al., 2009). Subunit coding sequences were ordered as native sequences or were
codon-optimized for nuclear expression in L. sativa. For gene expression in L. sativa
chloroplasts, a vector with a GoldenGate-compatible insertion site for protein-coding
genes was synthesized (BioBasic) (Figure 1). The 3’ end of the insertion site sequence:
GGTCTCTGAGC, was composed of the BsaI sequence GGTCTC, followed by any
nucleotide (T), then the designed sticky-end GAGC. Sequences were therefore ordered
with 3’ sequence GAGCTGAGACC to facilitate GoldenGate cloning. The 5’ insertion
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site sequence: CAAGTGAGACC, contains the reverse-complement of the BsaI site,
facilitating cutting in the other direction to generate a CAAG sticky-end. Sequences were
therefore also ordered with 5’ sequence GGTCTCTCAAG to facilitate GoldenGate
cloning. This chloroplast expression construct designated pLSCTGG contained a Cterminal c-Myc tag translationally fused to coding sequences within the insertion site,
which allowed detection of fusion proteins using Western blot. Another L. sativa
chloroplast transformation construct was generated using DNA sequences donated by Dr.
Heribert Warzecha (Technische Universitat Darmstadt, Germany) via a combination of
GoldenBraid and Sequence- and Ligation-Independent Cloning (SLIC) assembly
methods (Li et al., 2007b; Sarrion-Perdigones et al., 2011). GoldenBraid cloning makes
use of the GoldenGate principles, alternating usage of restriction sites BsaI and BsmBI in
destination vectors to facilitate iterative and potentially infinite addition of new
sequences. SLIC makes use of 5’ complementary overhangs on both strands of sequences
to be joined, added to each sequence by PCR using long primers. Annealing of
complementary sequences is facilitated by DNA recombination and repair protein, RecA.

2.2.2

GoldenGate cloning

Genes to be expressed either transiently or transplastomically were cloned into
destination vectors using GoldenGate technology. This technology utilizes BsaI sites
flanking each protein-coding gene, which cleave DNA outside enzyme recognition sites
upstream and downstream of each gene (Figure 1). This digestion generates DNA
fragments with compatible ends that allow ligation in a predetermined order. Specifically,
200 ng of each plasmid carrying a gene fragment was mixed with 200 ng of vector, 2 L
of CutSmart buffer (NEB), 2 L of 10 mM ATP, and 1 L of BsaI high-fidelity enzyme
(NEB), and 1 L of t4 DNA ligase (NEB). The volume of this reaction mixture was
adjusted to 20 L with MilliQ water, incubated for 16 hr at 37°C, then ethanolprecipitated.
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A)

B)

D)

C)

Figure 1. GoldenGate Cloning.
The BsaI enzyme recognizes the sequence GGTCTC (orange), and cuts one nucleotide
downstream of the recognition sequence on the top strand (as displayed), and five
nucleotides downstream on the bottom strand (scissor locations), generating an overhang
(green). Grey sequences are irrelevant to the assembly process. Arrows with plus signs
represent ligation of sequences with complementary overhangs. Longitudinally-split
arrows point to resulting ligation products.
A) The GOI (purple) is liberated from the donor vector via BsaI digestion, and BsaI sites
are not present in the fragment removed. B) The fragment containing the BsaI sites is
removed from the recipient vector via BsaI digestion. C) Through ligase activity, one new
product containing all BsaI sites can form, as can the original donor and recipient vector
with their fragments (A and B). However, these contain BsaI sites and can therefore be
re-cut. D) The intended product of Golden Gate assembly is formed from the insert and
the destination vector. This product does not contain any BsaI sites, and will therefore
predominate as BsaI continues to digest other sequence combinations.
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2.2.3

GoldenBraid and sequence- and ligation-independent
cloning

Gene sequences received from Dr. Warzecha (Darmstadt, Germany) were assembled to
form the L. sativa chloroplast transformation construct pHeri through GB cloning and
SLIC. Prior to GB cloning, expression elements were assembled alongside a selectable
marker, and flanking sequences were placed into GB-compatible vectors using
GoldenGate cloning as described in section 2.2.2. GoldenBraid cloning was then
conducted to assemble the upstream flanking sequence with the expression elements and
the selectable marker. GoldenBraid cloning used the same reaction recipe as GoldenGate
cloning described in section 2.2.2, but 1 BsmBI high-fidelity enzyme (NEB) was also
added to the reaction mixture. The mixture was incubated for 4 hr at 55°C, then 1 L of
T4 DNA ligase (NEB) was added and the reaction was incubated at an alternating 37°C
and 16°C for 10 min per cycle for 30 cycles. To assemble the downstream flanking
sequence with the other sequences combined by GoldenBraid, sequence- and ligationindependent cloning was conducted, as follows. For this, 2 g of pUC57 vector was
digested with 1 L of Bam HI restriction enzyme for 16 hr, separated on a 1% agarose
gel, and then the linearized vector was gel-purified using the QIAquick Gel Extraction
Kit (Qiagen). The GoldenBraid-assembled sequences and the downstream flanking
sequence were each amplified by PCR using primers immediately adjacent to the GOI,
designed with 5’ overhangs identical to the ultimately adjacent region of the other gene.
To each of the two PCR products, 1 L of Dpn I was added to digest template DNA, then
each was purified using the QIAquick Gel Extraction Kit (Qiagen). To each of the two
purified amplicons and purified vector, 1 L of T4 DNA polymerase (NEB) as an
exonuclease and 2 L of buffer 2.1 (NEB) were added, and the reaction was incubated
for 45 min at room temperature. One-tenth of each reaction volume of dCTP was added
to halt exonuclease activity, the two amplicons and vector reactions were combined, then
2 L T4 DNA ligase buffer (NEB) and 1 L of recA (NEB) were added to facilitate
DNA annealing.
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2.2.4

Subcloning of CPL

The CPL sequence was transferred from the L. sativa chloroplast expression construct to
a previously generated chloroplast expression cassette (CEC) for tobacco chloroplast
transformation (Kolotilin et al., 2013). In this procedure, alternate restriction enzymes
were employed to either retain or eliminate the t7g10 downstream box from the CEC.
Succinctly, CPL was amplified from pLSCTGG using a forward primer to add either a
NheI or SapI restriction site and a reverse primer that annealed downstream of a Not I site
immediately following the c-Myc tag. For 16 hr, 2 g of CEC was digested with 1 L of
NotI and 1 L of either NheI or SapI to generate fragments with and without a t7g10
downstream box, respectively. Additionally, 3 g of amplified CPL was digested with
enzymes corresponding to the sites added on the forward primer. The resulting fragments
were separated on a 1% (w/v) agarose gel, excised, and gel-purified using the QIAquick
Gel Extraction Kit (Qiagen). Purified DNA fragments were ligated together by
combining 500 ng of the CEC with 200 ng of digested CPL amplicon, 1 L of T4 DNA
ligase (NEB), and 2 L of 10 mM ATP. The volume of this reaction mixture was
adjusted to 20 μL with MilliQ water and incubated for 16 hr at 16°C.
To generate the vector pLSCTGG-P, the N. tabacum PpsbA sequence from the CEC
vector was used to replace the intercistronic expression element (IEE) sequence
originally present within the pLSCTGG vector. This was conducted by cutting both
vectors with BlpI and PvuII restriction enzymes to excise the desired fragments. Briefly,
at 10% (v/v) NEB buffer 2.1, 2 μg of pLSCTGG was cut overnight with 0.05 μL of
PvuII and 1.5 μL BlpI, while 4 μg CEC was cut with 1 μL of PvuII and 2 μL of BlpI. The
products were separated on a 1% agarose gel, and the desired linear fragments were
excised and extracted from the gel using the QIAquick Gel Extraction Kit (Qiagen,
Catalogue Number: 28704). Then 150 ng of each fragment was mixed with 2 μL of T4
DNA ligase (NEB), 2 μL T4 DNA ligase buffer, and 2 μL of 10 mM ATP. The volume of
this reaction mixture was increased to 20 μL and incubated for 16 hr at 16°C.
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2.2.5

E. coli transformations

All constructs generated through cloning procedures were subsequently ethanolprecipitated then transformed into electro-competent E. coli DH5α, with the exception of
the SLIC-generated pHeri and restriction-ligation-modified pLSCTGG-P, which were
transformed into chemically-competent E.coli. Briefly, ethanol precipitation was
conducted by adding sodium acetate (pH 5.2) to a final concentration of 0.3 M to the
sample. Half the sample volume of -20°C isopropanol was added, then the sample was
mixed and placed at -80°C for one hour. The sample was removed and centrifuged at 4°C
and 20 817 x g for ten min, the isopropanol removed, and 300 μL of -20°C 70% ethanol
was added. The sample was mixed and centrifuged at 20 817 x g for two min, then
ethanol removed, and lyophilized until dry. The sample was then resuspended in 10mM
Tris buffer, pH 8.0, generally to a volume of 10 μL. Each ethanol-precipitated reaction
was combined with 50 μL of E. coli and electroporated via the Gene Pulser II system
(Bio-Rad Laboratories Inc., Hercules, U.S.A,).
Chemical transformation was conducted by adding the entire reaction to 100 μL of cells,
incubating on ice for 15 min, then incubating at 42°C for 1 minute. Following
transformations, E. coli were diluted in 1 mL of lysogeny broth (LB) and incubated for
one hour at 37°C, shaking at 250 rpm (Innova® 42 Incubator, Eppendorf, Hamburg,
Germany), then 100 μL and 950 μL were spread onto LB plates with 50 μg/mL of
kanamycin or 100 μg/mL ampicillin.
Successfully transformed E.coli colonies were identified by PCR using primers specific
to genes inserted/combined within the recipient vector. PCR products were visualized on
a 1% agarose gel to confirm expected sizes. Colonies carrying the intended products were
grown in 15 mL LB with 50 μg/mL of kanamycin or 100 μg/mL ampicillin for
approximately 16 hr. To extract plasmid DNA from each culture, the QIAprep® Spin
Miniprep Kit (Qiagen, Venlo, Netherlands) was utilized according to the manufacturer’s
protocol.
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2.2.6

Sequencing

All altered regions of constructed vectors were sequenced prior to their use in either
infiltration for transient expression (section 2.3 and 3.3) or biolistic transformation
(section 2.4, 3.4, and 3.5). Sequencing reads were taken using primers that facilitated
coverage of a region adjacent to, and including the insertion site, demonstrating that the
correct insert was present. Sequencing was conducted by a technician at Agriculture and
Agri-food Canada’s London Research and Development Centre using an ABI PRISM
3130 xl Genetic Analyzer.

2.3
2.3.1

Transient Expression Assays
A. tumefaciens transformation

Transformation of electro-competent A. tumefaciens EHA105 was conducted as
described for E. coli (section 2.2.5) with the variation that A. tumefaciens were incubated
at 28°C shaking at 250 rpm after electroporation, and spread on LB plates with 50 μg/mL
kanamycin and 10 μg/mL rifampicin for a two-day incubation period at 28°C.
A. tumefaciens colonies were screened for successful transformants as described for
E.coli (section 2.2.5).

2.3.2

Transient expression in L. sativa and N. benthamiana plants

A. tumefaciens carrying transformed plasmids were inoculated into 3 mL of LB with 50
μg/mL kanamycin and 10 μg/mL rifampicin and grown for 16 hr at 28°C, shaking at 250
rpm. A 1/8500 dilution of these cultures, or a 1/4250 dilution of A. tumefaciens carrying
the p19 suppressor of gene silencing was then used to inoculate a 17 mL infiltration
culture composed of the same medium with added 10 mM 2-(N-morpholino)
ethanesulfonic acid (MES) at pH 5.6 and 100 μM acetosyringone. Infiltration cultures
were incubated at 28°C shaking at 250 rpm for 16 hr or until they reach an optical density
(OD) of 0.5-1.0, measured at 600 nm (OD600) using a Thermo Scientific Nanodrop 2000c
spectrophotometer. Infiltration cultures were then centrifuged at 6000 x g for 10 min,
resuspended to the desired OD in Gamborg’s solution: 3.2 g/L Gamborg’s B5 with
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vitamins, 20 g/L sucrose, 10 mM MES (pH 5.6) and 200 μM acetosyringone, then
incubated with gentle agitation for 1 hr at room temperature. Cultures of A. tumefaciens
were either infiltrated alone or co-infiltrated alongside an A. tumefaciens culture
harbouring a construct for the suppressor of post-transcriptional gene silencing from the
cymbidium ringspot tombusvirus, p19 (Silhavy et al., 2002). A. tumefaciens in
Gamborg’s solution was infiltrated into 6-7 week old L. sativa grown in the greenhouse
as described in section 2.1.1.1, watered with an optimized fertilizer concentration of 1.5
g/L 20-20-20 fertilizer. Infiltration was conducted by injecting each A. tumefaciens
suspension into the abaxial side of a leaf, using one leaf per treatment per plant, and a
minimum of three plants. Plants were returned to the greenhouse after infiltration and
sampled four days-post-infiltration (DPI). Tissue collection, total soluble protein
extraction, and quantification of total soluble protein were conducted as described
previously (section 2.1.1.2). Insoluble proteins were extracted from tissue samples
following extraction of soluble proteins, using the pellet remaining after withdrawal of
the supernatant fraction as the final step in soluble protein extraction. To extract insoluble
proteins the extraction buffer used was composed of 50 mM Tris-HCl pH 8.0, 1% sodium
dodecyl sulfate (SDS) (v/v), and 20 mM dithiothrietol (DTT).

2.3.3

Quantification of recombinant protein

Immunoblots featuring a standard curve of known protein concentrations were employed
to determine recombinant protein accumulation levels. Prior to immunoblotting, protein
extracts were mixed with a sample buffer to a final concentration of 1X, containing
0.06 M Tris-HCl pH 8.0, 1% (w/v), SDS, 2% (v/v) glycerol, 20mM DTT, and 0.01%
(w/v) Phenol Red. Samples were then heated to 95°C for ten min, and loaded into a
GenScript ExpressPlus™ 4-20% (w/v) polyacrylamide gradient alongside a dilution
series of a standard protein produced our lab called eGEHK composed of GFP with
elastin-like polypeptide (ELP), hydrophobin (HFBI), a polyhistidine (His)-tag, and a Cmyc tag. To size-separate proteins, gels were run at 140 V for 80 min using a Bio-Rad®
Power Pac 3000. Proteins were then transferred to a polyvinylidene difluoride (PVDF)
membrane using a Bio-Rad Trans-Blot® Transfer System at 25 V for seven min, then
blocked overnight in a 5% (w/v) skim milk powder in phosphate-buffered saline with
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0.1% (v/v) Tween-20 (PBS-T). To detect CPL with a c-Myc tag, the GenScript One-hour
Western™ Detection System kit was used. A solution of mouse anti-c-Myc antibody was
first mixed with a solution of rabbit anti-mouse secondary antibody, conjugated to
horseradish peroxidase (HRP). This mixture was then applied to the membrane in a
1:1000 dilution, which was incubated at room temperature with gentle agitation for 1 hr.
Membranes were thrice-washed for ten min with gentle agitation in TBS-T. Membranes
were then each incubated for five min in a 5 mL mixture of 2.5 mL Bio-Rad Clarity™
Western ECL peroxide and 2.5 mL Bio-Rad Clarity™ Western ECL enhancer.
Membranes were placed between clear plastic GEMEX report covers, and imaged using a
DNR Bio-Imaging Systems MicroChemi 4.2 operated through DNR Bio-Imaging
Systems Image Capture software. Quantities of recombinant protein in each lane of the
blot were determined by comparison of band intensities to those of the eGEHK standard
curve using Total lab TL100 software (Nonlinear Dynamics, Durham, USA). The
quantity of recombinant protein was then compared to both the total soluble protein,
determined by Bradford Assay as described in section 2.1.1.2, and the FW of leaf tissue
in each sample. The quantities of recombinant proteins, expressed as a percentage of total
soluble protein or mg/kg of fresh leaves, were compared amongst treatment groups as
described in section 2.1.1.2.

2.3.4

Recombinant protein characterization

To assay for glycosylation of CPL, enzymatic deglycosylation with PNGase-F was
employed. To remove the glycan side chains, 35 μL of protein extract from infiltrated
leaves was mixed with 10 μL of 250 mM disodium phosphate pH 7.5 and 2.5 μL 2%
SDS, 1M -mercaptoethanol, then heated to 100°C for five min. To this mixture, 2 μL of
PNGase-F enzyme (NEB) and 2.5 μL of 15% Triton X-100 were added. The reaction was
incubated at 37°C for 40 hr, then was analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting as described in
section 2.3.2.1. A positive control protein, known to be glycosylated in other
experiments, was treated in the same way, and analyzed alongside CPL on a Western
blot.

25

2.3.5

Protein subcellular localization

Confocal microscopy was used to localize transiently-expressed GFP within L. sativa
epidermal cells. Leaf discs 5 mm in diameter were collected at 4 DPI from L. sativa cv.
Simpson Elite or Rouge d’Hiver, and placed abaxial (infiltrated) side up on a glass
microscope slide on top of one drop of MilliQ water. Each leaf disc slide was visualized
using a Leica TCS SP2 inverted confocal microscope with a 63X water immersion
objective lens. For visualization of GFP, an argon laser at wavelength 488 nm was used
to excite GFP, while light emitted at wavelength 500-525 nm was monitored. To
visualize chloroplasts, the same excitation wavelength was employed, and light emitted at
wavelength 640-700 nm was monitored. Images taken using the two emission
wavelengths were overlaid using the Leica TCS SP2 software to create merged
images.

2.4
2.4.1
2.4.1.1

Generation of transplastomic plants
L. sativa chloroplast transformation
L. sativa biolistic transformation

L. sativa seeds of each of the four L. sativa cultivars were sterilized and grown as
explained in section 2.1.4. Seeds were grown for six weeks or until fully expanded
leaves, approximately 4 cm2 in size, appeared, then harvested. Biolistic transformation
was conducted as described previously for tobacco (Verma et al., 2008), with several
modifications. Briefly, 50 μL of 50 mg/mL 0.6 μm diameter gold particles were coated
with 20 μg of 1 μg/μL chloroplast transformation vector by mixing under agitation the
gold, vector, 50 μL of 2.5 M CaCl2, and 20 μL of 0.1 M spermidine. This mixture was
incubated for 15 min with agitation, and centrifuged prior to each wash. The pellet was
washed with 70% (v/v) ethanol, centrifuged once more, then with 100% (v/v) ethanol,
and resuspended in 50 μL of 100% (v/v) ethanol. The DNA-coated gold particles were
dispensed 10 μL each onto five macrocarriers and allowed to dry prior to each of five
bombardments. Fully expanded leaves were placed adaxial side up on a petri dish filled
with regeneration media (section 2.1.4) lacking spectinomycin. Leaves were bombarded
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using a Bio-Rad PDS-1000 / He™ Biolistic Particle Delivery System, using 1100 psi
rupture discs, under 29 mm Hg vacuum at a target distance of 9 cm. Following
bombardment, leaves were incubated in petri dishes of regeneration media composed of
L. sativa basal media with 0.2 mg/L BAP and 0.1 mg/L NAA lacking spectinomycin in
complete darkness at room temperature for two days, maintaining sterility. Leaves were
then divided and regrown as described in section 2.1.4, with the bombarded adaxial side
contacting the regeneration media containing spectinomycin. Leaves in petri dishes were
then incubated in conditions identical to those of seed growth until shoots were visible or
leaves appeared brown and dead after approximately 12 weeks. Calli with shoots were
divided and transferred to new dishes containing the same type of media.

2.4.1.2

Modifications to procedure

The biolistic transformation procedure was also conducted with L. sativa leaves placed
abaxial side up during bombardment and contacting the media following explanting.
Separately, target distance was altered from 9 cm to 11 cm, 6 cm, or 3 cm. In
combination with target distance alterations, three leaves were stacked on each petri dish
containing media. All three leaves were then divided and placed onto new plates. The
first-described procedure was also conducted with media used for regeneration following
bombardment containing 30 mg/L rather than 50 mg/L of spectinomycin. Also using the
same procedure, leaves of age 4-7 weeks were bombarded. Separately, the biolistic
apparatus was adjusted such that the macrocarrier was closer to the rupture disc.
Following a protocol provided by Dr. Fernando Bravo-Almonacid at the Institute for
Research on Genetic Engineering and Molecular Biology (Ingebi Conicet), Argentina,
some aspects of the chloroplast transformation protocol were altered. Prior to
bombardment, explanted leaves were placed adaxial side upward on petri dishes of the
basal media with 0.1 mg/L BAP and 0.1 mg/L NAA, held in darkness for one day. When
preparing DNA-coated gold particles, 3 mg of gold in 50 μL were mixed with 20 μg of
plasmid DNA, 50 μL of 2.5 M calcium chloride, and 20 μL of 0.1 M spermidine. This
mixture was agitated at room temperature for 20 min, and then washed by adding 200 μL
of 100% ethanol, vortexing for five sec, and centrifuging for 30 sec at 800 x g. Washing
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was repeated six times before the gold particles were spread onto five macrocarriers and
bombardment was conducted as previously mentioned.

2.4.1.3

Alternate L. sativa chloroplast transformation vectors

Two alternative L. sativa transformation vectors were generated. One vector consisted of
the original synthesized vector, with N. tabacum PpsbA cloned upstream of aadA, the
spectinomycin resistance gene (process described in 2.2.4). The PpsbA sequence replaced
the IEE originally present within the pLSCTGG vector to form the vector pLSCTGG-P.
The GFP gene was cloned into each the synthesized pLSCTGG and pLSCTGG-P by
GoldenGate cloning, as described (2.2.2). The second alternative vector consisted of
sequences donated by Dr. Heribert Warzecha and was assembled using GoldenBraid and
SLIC cloning technologies, as previously described (2.2.4). Each of these vectors was
employed in the unmodified biolistic transformation procedure for L. sativa using for a
minimum of 40 bombardments.

2.4.1.4

Assays for successful L. sativa transformants

Tissue was collected from putative transformants by taking three leaf discs, 9 mm in
diameter in a 2 mL tube with three silicon beads. These were flash frozen and
homogenized using a TissueLyser (Qiagen), then centrifuged at 4000 x g for one minute.
To the tube, 200 μL of DNA extraction buffer (200 mM Tris-HCl, 250 mM NaCl, 25 mM
EDTA, 0.5% SDS, pH 7.5) was added. The tube was vortexed twice, inverting between
each application, then centrifuged at 18000 x g at 4°C for two min. The supernatant was
transferred to a 1.5 mL tube, one volume of ice cold isopropanol was added, the sample
was mixed by inverting, then incubated at -20°C for 30 min. The sample was centrifuged
at 18000 x g at 4°C for five min, the supernatant was discarded, 200 μL 70% ethanol was
added to the tube. The pellet was dislodged by flicking the tube. The sample was
centrifuged at 18000 x g at 4°C for five min, and the supernatant discarded. The sample
was dried using an Eppendorf Vacufuge then resuspended in 50 μL of 10 mM Tris-HCl.
DNA from each putative transformant was PCR-amplified using gene-specific primers
and primers that annealed to native sequence outside the transgene insertion location.
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PCR was conducted for 35 cycles using a denaturation temperature of 94°C for 30 sec, an
annealing temperature of 55°C for 30 sec, and an extension temperature of 72°C for two
min. The plasmid used for biolistic transformation was amplified using the same primers
and compared to amplicons from putative transformants to assess whether transformation
had occurred.

2.4.2
2.4.2.1

N. tabacum chloroplast transformation
N. tabacum biolistic transformation and regeneration of
transplastomic plants

Sterilization of 81V9 N. tabacum seeds was conducted as mentioned for L. sativa seeds
(section 2.1.4), except no wash with bleach and Tween-20 was used. Seeds were grown
in the same basal medium used for L. sativa, for six weeks, or until fully-expanded leaves
appeared, roughly 10 cm2 in size, then biolistic transformation was conducted.
Transformation of 81V9 N. tabacum was conducted as first described for L. sativa,
except leaves were placed with adaxial side contacting the media during bombardment
and following explanting. The media used in N. tabacum regeneration consisted of basal
media with 1 mg/L BAP, 0.1 mg/L NAA, 1 mg/L thiamine hydrochloride, and 0.1 g/L
myo-inositol. Following three rounds of regeneration, each comprising explanting of leaf
tissue followed by callus-generation and growth of new shoots, meristems with attached
shoots were transferred to basal media. Meristems with shoots were grown until they
reached the top of their container and had noticeable root development, permitted by
growth in basal media lacking hormones. Plantlets were then transferred to soil and
grown in the greenhouse under the same conditions as greenhouse-grown lettuce. Growth
continued until plants flowered and seeds were produced. Those seeds were collected and
stored for later growth of transplastomic plants.

2.4.2.2

Confirmation of homoplasmy in transplastomic N. tabacum

Once all transplastomic plants containing CPL were growing in soil lacking selection,
and some plants had begun to flower, a Southern blot (Southern, 1975) was conducted to
evaluate homoplasmy. The Southern blot makes use of a detectable probe complementary
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to regions flanking the insertion site, and allows detection of DNA with or without
insertions, which is transformed or wild type, respectively. For use in this Southern blot,
a DIG-labelled probe was prepared previously by PCR using primers that annealed within
the trnI and trnA flanking regions of the insertion site (Figure 2) (Kolotilin et al., 2012).
This PCR utilized digoxigenin (DIG)-labelled nucleotides (Roche DIG High Prime DNA
Labeling and Detection Starter Kit II). Following PCR, the probe was denatured at 95°C
for 5 min, then frozen at -20°C until use. Ten leaf discs were collected from each plant
using a 7 mm cork borer and flash frozen in liquid nitrogen. DNA was extracted from
these leaf discs using the Qiagen DNeasy plant mini kit, according to the manufacturer’s
instructions, and DNA was quantitated by the Nanodrop instrument (manufacturer,
location). A 0.8% agarose, 0.5X TAE (Tris base, acetic acid, EDTA) gel was used to
separate 5 μg of each sample to assess purity. 10 μg of each sample was digested at 37°C
overnight using 20 units of RsrII in a total volume of 20 μL at 1X cutsmart buffer. To
each sample, 4 μL of 6X bromophenol blue loading buffer was added, and 2 μL of
sample ran on a 0.8% agarose, 1X TAE gel to assess digestion. The remainder of each
sample was loaded onto a 0.8% agarose, 1X TAE gel alongside a DIG-labelled molecular
weight marker from the DIG-High Prime DNA Labeling and Detection Starter Kit II
(Roche Diagnostics, Basel, Switzerland) and ran at 70 V for three hours. The gel was
depurinated in 500 mL of 0.2 M HCl, shaking for 30 min, then denatured while shaking
for 30 min in 500 mL of 0.5 M NaOH, 1.5 M NaCl. The gel was neutralized while
shaking for 30 min in 500 mL of 1 M Tris-Cl, 1.5 M NaCl, pH 8.0, then incubated for 30
min while shaking in 10X SSC (1.5 M NaCl, 0.15 M sodium citrate). DNA was
transferred from the gel to a Hybond N+ nylon membrane by placing the membrane on
top of the gel, and pressing the gel and membrane together using glass plates and a 0.5 kg
weight atop the upper plate. DNA was crosslinked to the membrane using a Thermo
Fisher Scientific FB UVXL-1000 UV crosslinker set to 1200 units, ran for one min. The
blot was then rinsed with MilliQ water, then with 6X SSC and transferred to a
hybridization tube, to which 20 mL of pre-hybridization solution containing 15.6 g of
DIG Easy Hyb Granules (Roche cat# 11 796 895 001) was added. The blot within the
tube was incubated at 50°C for one hour, rotating at 8 revolutions/minute (rev/min). The
DIG-labelled probe in pre-hybridization solution was defrosted at 68°C for 10 min then
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Figure 2. Targeted integration sites within the L. sativa and N. tabacum chloroplast
genomes.
All constructs target both regions between the repeated trnI and trnA genes with the
exception of pHeri, which targets the rcbL-accD region. LSC: Long single copy region,
SSC: Short single copy region, IR A/B: Inverted repeat region A and B, 16S rRNA: 16S
ribosomal RNA, trnI: transfer RNA isoleucine, trnA: transfer RNA alanine, Ls rbcL:
L. sativa chloroplast RuBisCo Large chain, Ls accD: L. sativa acetyl-coenzyme A
carboxylase subunit B.
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pre-hybridization solution was removed from the hybridization tube and replaced with
the probe solution. The tube with the probe and membrane was incubated at 50°C
rotating at 8 rev/min overnight. The hybridization solution was removed from the tube
and the membrane was washed twice at room temperature for 15 min each in 100 mL
0.1% SDS, 2X SSC, rotating at 10 rev/min. The membrane was then washed thrice for
1.5 hr each at 68°C in 100 mL 0.1% SDS, 0.5X SSC, rotating at 10 rev/min. The
membrane was then washed in 0.3% tween 20, maleic acid buffer (0.1 M maleic acid,
0.15 M NaCl, pH 7.5) at 48°C for five min, rotating at 8 rev/min. The membrane was
blocked overnight at 48°C in 100 mL blocking buffer (1% Roche Blocking Reagent in
maleic acid buffer), and 24 mL of 48°C anti-DIG antibody solution (24 mL blocking
buffer with 1.714 μL anti-DIG antibody) was added prior to incubation for one hour at
48°C, and the blot washed twice for 30 min at 48°C in maleic acid buffer with 0.3%
Tween-20. To the hybridization tube, 20 mL of detection buffer (0.1M Tris-HCl, 0.1 M
NaCl, pH 9.5) was added, and the blot was incubated at room temperature for 10
min. The blot was removed from the tube, placed between clear plastic sheets, and 1 mL
of Chloro-5-substituted adamantyl-1, 2-dioxetane phosphate solution (Roche, SKU
11655884001) was added directly to the membrane surface. The membrane was
incubated at room temperature for five min, then sealed between the sheets and incubated
for ten min at 37°C. The sealed membrane was imaged using a DNR Bio-Imaging
Systems (Jerusalem, Israel) MicroChemi 4.2 imager to visualize bands corresponding to
wild type and transformed chloroplast genomes.

2.4.2.3

Assessment of developmental effects of transplastomic
recombinant protein gene

Transplastomic N. tabacum were transferred from sterile basal media to soil following a
minimum of three rounds of regeneration. Wild type plants were grown in sterile media
to the same size as regenerated transplastomic N. tabacum, and transferred to soil
simultaneously. Transplastomic and wild type N. tabacum were each measured weekly to
determine their height, the length and width of the largest two leaves present, and the
total number of non-chlorotic leaves longer than 2 cm growing from the main stem.
Measurements continued until seeds could be collected, at which point the plant was
32

discarded. Sizes of transplastomic and wild type plants according to each measured
variable at each time point were compared by Student’s t-test. Lines of best fit were
developed for each variable using Excel regression function to produce a fourth-order
polynomial equation.

2.4.2.4

Assessment of developmental dependence of recombinant
protein accumulation

Once each transgenic tobacco plant had 10 leaves over 15 cm in length, near the time of
flowering, tissue was sampled from each leaf. Soluble and insoluble proteins were
extracted from each sample as previously described (section 2.1.1.1 and 2.3.2). The
accumulation of the recombinant protein in each leaf was determined by Western blotting
as described in section 2.3.2.1. Recombinant protein in each leaf was compared as
described in section 2.1.1.2.

2.4.2.5

Quantification of recombinant protein accumulation in
transplastomic N. tabacum

Using data acquired from developmental dependence experiment, recombinant protein
accumulation in soluble and insoluble fractions was compared. The amount of
recombinant protein in each fraction was averaged across the ten sampled leaves, and the
two fractions were compared and added to calculate total average recombinant protein
accumulation throughout the plant. The amount of protein in each soluble and insoluble
fraction of six plants was compared via Student’s t-test.

2.4.2.6

Stability of transplastomically-produced recombinant
protein following lyophilization

Plants were sampled by taking eight leaf discs, 9 mm in diameter, in a 2 mL tube with 3
silicon beads. Eight additional discs were taken from a location adjacent to the first, and
placed in another tube. Both samples were flash frozen, and one was lyophilized using
the FreeZone 18 Liter Console Freeze Dry System. Samples were homogenized for two
1-minute intervals using a TissueLyser and extraction from both lyophilized and fresh
33

leaf tissue was conducted as previously described using the SDS-based protein extraction
buffer previously defined for insoluble protein extraction. An extraction buffer volume of
eight times the original sample mass (measured prior to lyophilization or freezing) was
used for extraction of recombinant protein. This was intended to extract total protein,
soluble and insoluble, in one buffer. Tissue within tubes lacking beads was ground by
hand using a mortar and pestle after extraction buffer was added. Proteins were separated
by SDS-PAGE and analyzed by western blot, using known amounts of a standard protein
to quantify each sample, as previously described in section 2.3.2.1. The amount of protein
in fresh and freeze-dried samples was compared via Student’s t-test.
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Results
3.1
3.1.1

Improvement of L. sativa as a laboratory model
First evaluation of fertilizer dependence of lettuce growth

To determine the best fertilizer, and concentration of that fertilizer, that could be used to
produce the largest and highest protein-content in lettuce cv. Simpson Elite, experiments
were conducted to compare fertilizers and multiple concentrations. In the first
experiment, plants were watered with 1 g/L, 1.5 g/L, or 2.0 g/L of fertilizers of 20-20-20,
20-8-20 or 19-8-13 percentage of nitrogen to phosphorus to potassium. As controls,
plants were also grown in the growth room with no fertilizer. Plants were grown in a
growth room or a greenhouse. Greenhouse-grown plants were significantly larger than
those grown in the growth room, averaging 111 g FW, compared to 29 g FW for the
growth room-grown plants watered with the same fertilizer, 1 g/L of 20-8-20 (Figure 3a).
Among the growth room-grown plants, few significant differences exist between
treatment groups (plants grown with different fertilizer type or concentration). However,
plants watered with 1.5 g/L or 2.0 g/L 19-8-13 fertilizer had significantly lower FW than
those watered with any concentration of 20-20-20 or 20-8-20 fertilizer, except those
watered with 2.0 g/L of 20-20-20 fertilizer. The best growing group with regard to FW
was 1 g/L 20-8-20, although this was only significantly higher than the 19-8-13 fertilizer
groups and the unfertilized plants. The unfertilized plants were significantly smaller than
all fertilized plants. Protein content per FW was not significantly different among any of
the growth room-grown groups, and greenhouse-grown plants had significantly higher
protein than 1.5 g/L and 2.0 g/L 19-8-13 plants. Measurements of DW and protein per
DW (Figure 3b) revealed few statistically significant differences in plant performance,
with the exception of plants fertilized with 19-8-13 fertilizer, which have generally lower
protein content than those watered with the other two fertilizers. Analysis of TSP per
plant displayed similar trends to FW (Figure 3c), with greenhouse-grown plants
significantly higher than all others, and 19-8-13 plants generally accumulating less
soluble protein, with significant differences between 19-8-13 plants and some other
groups. From this experiment, it was concluded that greenhouse growth
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Figure 3. First evaluation of fertilizer dependence of L. sativa growth.
L. sativa cv. Simpson Elite plants grown in a growth room or a greenhouse. Four plants
were grown under each treatment. Error bars represent standard error of the mean.
Treatments that are not labelled with the same letter are significantly different. The Y
axes are colour coded, with corresponding colour bars. Measurements displayed in one
colour were compared only to measurements of the same trait, displayed in the same
colour.
A) Fresh weight and protein content per fresh weight of L. sativa. B) Dry weight and
protein content per dry weight. C) Total soluble protein content per plant.
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of lettuce plants is likely superior to growth within a growth room, and the 19-8-13
fertilizer was discarded from further tests as plants watered with that fertilizer generally
performed worse than those watered with the other two fertilizers.

3.1.2

Light intensity dependence of L. sativa growth

Hypothesizing that greenhouse-grown L. sativa plants may be larger due to a higher light
intensity, an experiment was conducted to investigate light intensity effects on L. sativa
growth. Based on the greenhouse light intensity of roughly 200 M/m2/s, this experiment
compared plants that received light at an intensity above and below that experienced in
the greenhouse, at intensities that could be made approximately equal for multiple plants
under each treatment using the lighting available. The lower light intensity was intended
to be closer to that of the greenhouse, at an average of 173 μM/m2/s, while the higher
light intensity was above that of the greenhouse, at an average of 260 μM/m2/s. Eight
plants were grown in each group, and all were watered with 1 g/L 20-20-20 fertilizer. No
significant differences were found between the two treatments in any of the variables
tested: FW (Figure 4A), DW (Figure 4B), protein content per FW (Figure 4A) or DW
(Figure 4B), or total protein content per plant (Figure 4C). Therefore, at the levels tested,
it could not be concluded that light intensity has any effect on plant size or protein
content. Following these results, plants were grown exclusively in the greenhouse, as
growth in that environment could not be replicated within growth chambers or growth
rooms.

3.1.3

Evaluation of fertilizer dependence of lettuce growth in the
greenhouse

The first fertilizer growth experiment was repeated in the greenhouse to determine
whether differences exist between plants grown in that location. Six plants were used per
treatment as biological replicates. Of the six groups tested (Figure 5), the 1.5 g/L 20-2020 group tended to yield the highest measurements, although no significant differences
exist between this group and the 1 g/L 20-20-20 group. Measurements of FW and DW
showed the fewest significant differences between test groups, indicating only that the 0.5

38

g/L groups performed worse than higher fertilizer concentrations, without pointing to any
specific fertilizer type or concentration as most effective. However, differences in protein
content, measured as protein either per weight or per plant (Figure 5C), and were
significant, with the 1 g/L and 1.5 g/L 20-20-20 fertilizer outperforming all other groups,
although no significant differences existed between the two best-performing groups. It
was concluded from this experiment that 1.5 g/L of 20-20-20 fertilizer should be used to
maximize Simpson Elite lettuce growth and protein content, although 1 g/L 20-20-20
fertilizer may be substituted to reduce fertilizer costs.

3.1.4

Comparison of protein content in L. sativa, N. benthamiana,
and N. tabacum

To determine which L. sativa cultivar is most suitable for recombinant protein
production, the total soluble protein content of four cultivars was evaluated. As a
prediction of recombinant protein accumulation in L. sativa relative to other production
platforms, protein content of the L. sativa cultivars was compared to that of
N. benthamiana and N. tabacum. It was determined (Figure 6) that L. sativa cv. Romaine
and Rouge d’Hiver have a higher protein content than the Simpson Elite cultivar. It was
also determined (Figure 6) that N. tabacum cv. 81V9 has a higher protein content than the
other two species analyzed, and that N. benthamiana has a similar protein content to
Simpson Elite lettuce. Since the Simpson Elite cultivar was ultimately used in future
experiments, recombinant protein accumulation levels were expected to be similar to
those found in N. benthamiana and below those found in N. tabacum.

3.1.5

Initiation of L. sativa flowering

To develop a simple protocol to collect seeds for storage and future analysis, each
cultivar of L. sativa was induced to flower and to produce seeds. It was determined that
growth in the greenhouse (described in section 2.1.1.1) for an extended period of time, up
to 95 days, can cause each cultivar to flower. According to cultivar, L. sativa plants were
found to require different lengths of time to flower and produce seeds (Figure 7). It was
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Figure 4. Light-intensity dependence of L. sativa growth.
L. sativa cv. Simpson Elite plants grown in a growth cabinet with 1 g/L 20-20-20
fertilizer. Six plants were grown under each treatment. Red bars represent protein content
and green bars represent plant weight. Error bars represent standard error of the mean.
Treatments that are not labelled with the same letter are significantly different. Groups
represented by bars labelled with capital letters were compared only against other groups
with capital letters, and those with lower-case letters compared only against others with
lower-case letters.
A) Fresh weight and protein content per fresh weight. B) Dry weight and relative protein
content. C) Total soluble protein content.

41

A)

B)

C)

42

Figure 5. Second evaluation of fertilizer dependence of L. sativa growth.
L. sativa cv. Simpson Elite plants grown in a greenhouse. Six plants were grown under
each treatment. Red bars represent protein content and green bars represent plant weight.
Error bars represent standard error of the mean. Treatments that are not labelled with the
same letter are significantly different. Groups represented by bars labelled with capital
letters were compared only against other groups with capital letters, and those with
lower-case letters compared only against others with lower-case letters.
A) Fresh weight and protein content per fresh weight. B) Dry weight and protein content
per dry weight. C) Total soluble protein content.
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Figure 6. Comparison of protein content in L. sativa, N. benthamiana, and
N. tabacum.
The protein content of two species of Nicotiana and four cultivars of L. sativa. Error bars
represent standard error of the mean. Treatments that are not labelled with the same letter
are significantly different. Three L. sativa of each cultivar, four N. benthamiana, and
seven N. tabacum plants were analyzed.
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Figure 7. Initiation of flowering and seed production of four cultivars of L. sativa.
A) Pictured left to right (age 65 days): Rouge d’hiver, three Romaine plants, two
Simpson Elite plants. Only the first three plants show flowers. B) Flowering time of four
lettuce cultivars. C) Time until first appearance of seeds of four lettuce cultivars.
Eight plants of each cultivar were measured. Error bars represent standard error of the
mean. Treatments that are not labelled with the same letter are significantly different.
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found that L. sativa cv. Simpson elite and Iceberg take longer to flower and produce
seeds than Romaine and Rouge d’Hiver cultivars.

3.1.6

Regeneration of L. sativa

To determine the optimal hormone combinations for regeneration of each of the four
L. sativa cultivars considered in this study, regeneration experiments were conducted.
Each of the four cultivars responded differently to different hormone concentrations, and
there are inherent differences in regenerability (Figure 8). The Simpson Elite cultivar
(Fig. 8 B) regenerates more efficiently than Iceberg (Fig. 8A), Romaine (Fig. 8C), and
Rouge d’Hiver (Fig. 8D), as measured by number of shoots present five weeks after
explanting. The cultivars other than Simpson Elite regenerate at similar efficiencies (Fig.
8E). The Simpson Elite cultivar regenerates most efficiently under the 0.1 mg/L NAA,
0.2 mg/L BAP, 0.1 mg/L NAA, 0.3 mg/L BAP, and 0.2 mg/L NAA, 0.4 mg/L BAP
combinations. That 0.1 mg/L NAA, 0.2 mg/L BAP and 0.2 mg/L NAA, 0.4 mg/L BAP
yield similar results suggests that regeneration may be dependent upon hormone ratio
rather than quantity. However, as 0.05 mg/L NAA, 0.1 mg/L BAP led to less efficient
regeneration suggests that some minimal hormone concentration at an equal NAA:BAP
ratio is necessary for efficient regeneration. From these results, it appears 0.1 mg/L NAA,
0.2 mg/L BAP is sufficient for maximal regeneration of L. sativa cv. Simpson Elite.
Other cultivars displayed similar trends, with the same three hormone combinations
eliciting similar high regeneration efficiencies, although these were lower than those
observed in Simpson Elite (Figure 8). The results of this experiment led to adoption of
Simpson elite as the main cultivar for this study, as successful chloroplast transformation
is heavily dependent upon plant regeneration.

3.2

M. haemolytica vaccine design

Experimentally effective subunit vaccines for M. haemolytica have been designed and
sequence information made available (Ayalew et al., 2008; Ayalew et al., 2009; Confer et
al., 2009a; 2009b). These vaccines comprise two M. haemolytica proteins: outer
membrane lipoprotein E (plpE) and leukotoxin (Lkt), and a protein subunit of the cholera
toxin originating from Vibrio cholerae, cholera toxin B (CTB). Vaccines containing CTB
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Figure 8. Regeneration of four cultivars of L. sativa under different hormone
concentrations.
A total of 120 explants per treatment for each cultivar regenerated for six weeks with
varying concentrations of BAP and NAA. Error bars represent standard error of the
mean. Treatments that are not labelled with the same letter are significantly different. A
star indicates the optimal regeneration medium for each cultivar, as defined by the
highest number of shoots per plate. The optimal medium may not be statistically different
from some other media.
A) Iceberg. B) Simpson Elite. C) Romaine. D) Rouge d’Hiver. E) Each cultivar
regenerated within its hormone-optimized regeneration media, indicated in the cultivarspecific graphs by a star. Error bars represent standard error of the mean.
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translationally fused to Lkt and plpE are more effective than those composed of Lkt and
plpE alone (Ayalew et al., 2009). Therefore, a vaccine composed of CTB alongside
immunogenic, neutralizing target regions of Lkt (nLkt) and the antigenic r2 epitope of
plpE (rPlpE) was designed. As in the published sequence of an experimentally effective
vaccine, CTB was placed at the N-terminus, nLkt at the C-terminus, and rPlpE between
the other two protein fragments (Ayalew et al., 2009). Each fragment was separated by a
flexible glycine-proline-glycine-proline linker to allow independent folding and activity.
The sequences of Lkt and plpE represent serotype A1, the most common strain of
M. haemolytica associated with BRD. These sequences were synthesized in their native
form for chloroplast expression, and were codon-optimized for expression from the
lettuce nucleus for transient expression.

3.3
3.3.1

Transient production of recombinant proteins
Genetic constructs for transient expression of recombinant
protein

The CPL chimeric recombinant protein was produced transiently as a representation of
accumulation levels in the chloroplasts of transplastomic plants. It is hypothesized that
proteins expressed from the nucleus that accumulate well when transported into the
chloroplasts will also accumulate well when produced within the chloroplasts, as
accumulation is largely dependent upon the stability of each protein in its subcellular
location (Bock, 2015). Transient expression of CPL also served as a potential production
method. The protein subunits of CPL codon-optimized for L. sativa nuclear expression
were cloned into the destination vectors pCLGG-CHL and pCLGG-ER (Figure 9) for
trafficking of the protein to the chloroplast stroma and endoplasmic reticulum,
respectively. This trafficking was accomplished by use of signal peptides translationallyfused to the recombinant protein that target the protein to different intracellular
organelles. Proteins were targeted to the chloroplast using an N-terminally fused rubisco
small subunit transit peptide (rbcS), which interacts with the translocons of the outer and
inner membrane of the chloroplast to facilitate ATP and GTP-dependent import (Chen et
al., 1999). Proteins were targeted to the ER through use of a C-terminally-fused ER
49

retrieval tetrapeptide (KDEL), which facilitates retrieval of peptides from the Golgi
apparatus to the ER (Munro et al., 1987).
In addition to these targeting sequences, constructs each contain left and right T-DNA
border sequences to allow A. tumefaciens–mediated transformation of plant cells.
Expression of foreign proteins is driven by a double-enhanced 35S promoter from
cauliflower mosaic virus (2X35S) (Covey et al., 1981) and translation efficiency
improved by the tCUP translational enhancer, a cryptic gene activation sequence of
tobacco (Wu et al., 2001). In the ER-targeting vector the recombinant protein has an Nterminally-fused pathogenesis-related-1b protein (PR1b) signal peptide (Linthorst et al.,
1991). A c-Myc tag is translationally fused to the C-terminus of the protein of interest in
each vector, upstream of the KDEL tag in the ER-targeting vector. Transcripts encoding
the GOI with translational fusions are transcriptionally-terminated and stabilized by the
terminator and 5’ UTR of the nopaline synthase gene (nosT) (Figure 9).
Since there is extensive evidence that post-transcriptional gene silencing leads to foreign
transcript degradation (Voinnet, 2001), the cultures of A. tumefaciens harboring foreign
gene expression constructs were co-infiltrated alongside an A. tumefaciens culture
harbouring a construct for the suppressor of post-transcriptional gene silencing, p19
(Silhavy et al., 2002). As a negative control, the A. tumefaciens strain carrying p19 was
infiltrated in the absence of A. tumefaciens carrying gene-expression constructs.
Following infiltration, leaves of L. sativa or N. benthamiana plants were faintly yellowed,
with a ring of visible necrosis at the precise location of infiltration (data not shown),
presumably due to infiltration pressure. Infiltrated leaf tissue was sampled at 4 DPI and
proteins were extracted then analyzed by Western blot to quantify protein accumulation.

3.3.2

Quantification of transiently-produced recombinant protein

Western blots conducted using protein extracts from L. sativa and N. benthamiana plants
transiently expressing the CPL protein revealed that the protein in some cases
accumulates as a larger molecule than the expected 35.5 kDa, with size differences
depending on the compartment to which the protein is targeted (Figure 10).
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Figure 9. Genetic constructs for transient expression of recombinant proteins.
A schematic displaying two gene constructs used for transient expression of CPL in
L. sativa and N. benthamiana. 2x P35S: double-enhanced 35S promoter from cauliflower
mosaic virus, tCUP TE: cryptic gene activation sequence or translational enhancer of
tobacco, Xpress: tag for detection, CPL: candidate vaccine coding sequence, c-Myc: tag
for detection, TNOS: nopaline synthase terminator.
A) rbcS-SP: rubisco small subunit transit peptide. B) PR1b-SP: pathogenesis-related-1b
protein signal peptide, KDEL: ER retrieval tetrapeptide.
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Figure 10. Quantification of transiently-produced recombinant protein.
Four plants were infiltrated for each treatment with A. tumefaciens carrying each of the
constructs shown in Figure 9 co-infiltrated with p19, or with p19 alone (shown in lanes
labelled p19). S: soluble proteins, I: insoluble proteins. eGEHK: protein standard used for
quantification.
A) Protein accumulation in L. sativa. B) Protein accumulation in N. benthamiana.
C) Accumulation of CPL protein per FW in different fractions within different
compartments of N. benthamiana and L. sativa. Accumulation in soluble and insoluble
fractions was combined to calculate total accumulation. Error bars represent standard
error of the mean. Means that are not labelled with the same letter are significantly
different. Bars labelled with lower-case letters represent extract fractions, and were not
compared against bars labelled with capital letters, which represent extract totals.
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In L. sativa (Figure 10A), the CPL protein accumulates only within the chloroplasts as an
insoluble fraction of size 37 kDa, roughly equal to the expected 35.5 kDa. In
N. benthamiana (Figure 10B), the soluble form of CPL targeted to the chloroplast
accumulates at roughly the expected size, but also as a larger molecule than expected, at
approximately 43 kDa. One potential explanation of this size increase is the presence of
the rubisco transit peptide, which is roughly 6 kDa, and is assumed to be cleaved off in
the chloroplast (explored in section 4.3). In the ER, CPL accumulates as an even larger
molecule, approximately 47 kDa. This size increase may be explained by protein posttranslational modifications (explored in section 4.3). Statistical analysis by t-test revealed
that CPL accumulates in the chloroplast to significantly higher levels in an insoluble than
in a soluble form. Conversely, CPL accumulates in the ER to significantly higher levels
in a soluble than in an insoluble form. No significant difference was found between total
accumulation in the chloroplast and the ER. Since the soluble, monomeric form of the
CPL is most likely to expose immunologically important epitopes, ER-targeting of this
recombinant protein may be more useful than chloroplast-targeting. However, the
increase in size of the ER-targeted protein may be caused by protein modifications that
could potentially obstruct epitopes, thereby decreasing candidate vaccine efficacy. Which
cellular compartment is most suitable for candidate vaccine production would be best
determined by a vaccination study in animals.

3.3.3

ER-targeted CPL is not glycosylated

Hypothesizing that increases in size of the ER-targeted CPL protein were caused by Nglycosylation, an experiment to reveal the presence of N-glycosylation was conducted.
This experiment made use of the enzyme PNGase-F, which removes N-glycans
(Tarentino et al., 1994; Tarentino et al., 1989). Western blots of proteins treated with
PNGase-F compared to untreated proteins showed no detectable size shift of the CPL
band (Figure 11). However, PNGase-F treatment did reduce the size of a positive control
protein, which is a longer length plpE fragment produced in our lab, previously shown to
be glycosylated by PNGase-F treatment (data not shown). Therefore, it was concluded
that the ER-targeted CPL protein is not glycosylated following transient expression in
plant cells, and the visible size increases must be due to other reasons.
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Figure 11. ER-targeted CPL protein is not glycosylated.
Soluble protein extracts from infiltrations with ER-targeted CPL expression constructs
were pooled from four plants and treated with PNGase-F to remove N-glycans. A
positive control plpE fragment previously shown to be glycosylated was used for
comparison. +: PNGase-F treated, -: not PNGase-F treated, I: insoluble fraction.
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3.3.4

Protein subcellular localization in L. sativa

To verify that protein tags previously designed for N. benthamiana are functional in
L. sativa cells, CPL was replaced with GFP in the transient expression constructs.
A. tumefaciens-mediated transient expression was conducted using GFP with an Nterminally fused RbcS transit peptide for chloroplast-targeting, or Pr1b and KDEL for
ER-targeting. This allowed subcellular localization of GFP, and assessment of the
functionality of transit peptides. One reason transient expression was conducted using
vectors that target CPL to the chloroplast was to determine whether CPL could
accumulate well in that compartment. Subcellular localization allows verification that
proteins fused to the RbcS transit peptide indeed enter the chloroplast, and therefore can
be used as a representation of protein stability in that compartment. Confocal microscopy
revealed that GFP targeted to either the chloroplast or ER does accumulate within the
targeted subcellular compartment, and is not detectable elsewhere in the cell (Figure 12).
This can be visualized in the chloroplast by co-localization with the red autofluorescence
signal emitted by chlorophyll pigment under UV light. However, not all chloroplasts
within a given cell exhibit green fluorescence, and some chloroplasts fluoresce more
brightly than others. This can be explained by unequal reception of GFP from the
cytoplasm: by chance, some chloroplasts are more accessible than others, or possess more
active import systems, and therefore accumulate more GFP. Additionally, some cells
show less or no fluorescence at all. This can be explained by imperfect infection by
A. tumefaciens, which does not infect every epithelial cell, and can transfer different
numbers of T-DNA to different cells (Gelvin, 2003). It is not known which of the
chloroplasts shown in Figure 12 are within the same cell. It is possible that fluorescing
chloroplasts are within an infected cell, and non-fluorescing chloroplasts are within an
uninfected cell.

3.4
3.4.1

Attempts to generate transplastomic L. sativa
Genetic constructs for generation of transplastomic L. sativa

Multiple vectors were designed for transformation of lettuce chloroplasts (Figure 13). To
facilitate homologous recombination with the plastid genome, the first cassette
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Figure 12. Protein subcellular localization in L. sativa.
L. sativa expressing GFP targeted to either the chloroplast or ER and was then viewed
using a confocal microscope. GFP was visualized at a wavelength of 500-525 nm, and
chloroplast auto-fluorescence was visualized at a wavelength of 640-700 nm.
Fluorescence of GFP was captured and is shown in these images as green colour, while
chloroplast autofluorescence under UV light was captured and is shown as red colour.
The two images were merged to show whether GFP was co-localization with
autofluorescing chloroplasts. GFP expression constructs were co-infiltrated with p19.
A) Chloroplast-targeted GFP. B) ER-targeted GFP. C) p19 without GFP.
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Figure 13. L. sativa chloroplast transformation and expression constructs.
Genes CPL and GFP were cloned into the first-designed transformation vector (A), and
modifications were made to produce subsequent vectors (B and C). The final vector was
assembled separately, and each vector was used in minimally 40 bombardments.
Ls rrn16 +trnI: L. sativa 16S ribosomal RNA and transfer RNA isoleucine, IEE:
intercistronic expression element, aadA: aminoglycoside-3’ –adenyltransferase, TpsbC:
terminator of poplar photosystem II chlorophyll protein, PpsbA: L. sativa plastid
promoter of photosystem II protein D1, T7g10 5’ UTR: E. coli phage 7 gene 10 5’ UTR,
c-Myc: tag for detection, TrcbL: 3’ UTR and terminator of the white poplar chloroplast
RuBisCo Large chain gene. Ls trnA + rrn23: L. sativa transfer RNA alanine and 23S
ribosomal RNA.
A) pLSCTGG(CPL): The pLSCTGG construct with candidate vaccine gene coding
sequence inserted. CPL: CTB-rPlpE-nLkt. B) pLSCTGG(GFP): The pLSCTGG construct
with GFP coding sequence inserted. GFP: green fluorescence protein. C) pLSCTGGP(GFP): The pLSCTGG construct modified to form pLSCTGG-P, by replacing IEE with
Nt. PpsbA: the N. tabacum plastid promoter of photosystem II protein D1. D) The
minimal vector pHeri. Ls rbcL: L. sativa chloroplast RuBisCo Large chain gene, Nt. Prrn:
N. tabacum ribosomal operon promoter, Ls Trps16: L. sativa ribosomal protein S16
terminator, Ls accD: L. sativa acetyl-coenzyme A carboxylase subunit B.
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(Figure 13A), termed pLSCTGG, contains upstream flanking sequences of 16S ribosomal
rna (rrn16) then transfer RNA isoleucine (trnI) and downstream transfer RNA alanine
(trnA) then 23S ribosomal rna (rrn23) to facilitate cassette integration between trnI and
trnA genes of the ribosomal RNA (rRNA) operon within the inverted repeat regions of
the L. sativa chloroplast genome (Figure 2). The targeted integration site of this vector
lies within the ribosomal operon, which has read-through transcription, allowing
production of trnI, trnA, and any genes between them without a dedicated promoter.
Genes transcribed together in this manner, share a single mRNA transcript. Within the
flanking sequences, from furthest upstream to downstream, pLSCTGG contains an IEE
from N. tabacum. The IEE present on pLSCTGG facilitates cleavage of the inserted
sequences from the native ribosomal operon sequences to promote efficient transgene
expression as a separate transcript (Zhou et al., 2007). Downstream of the IEE lies the
aminoglycoside-3’-adenyltransferase (aadA) gene, which confers spectinomycin
resistance (Svab et al., 1990). The aadA gene is expressed in transgenic plants due to
read-through transcription of the rRNA operon, and a Shine-Dalgarno sequence is
included immediately before the aadA gene to facilitate ribosome binding. Transcription
of the aadA gene is terminated and the transcript stabilized by the terminator and 3’
untranslated region (3’ UTR) of photosystem II chlorophyll protein (CP) (TpsbC) of
poplar. Expression of the GOI is driven by the L. sativa plastid promoter of photosystem
II protein D1 (PpsbA) (Kanamoto et al., 2006). Stability of the GOI is provided by the 5’
UTR of the E. coli phage 7 gene 10 (T7g10). The GOI insertion location lies after the
PpsbA sequences and allows insertion by golden-gate cloning. Translationally fused to
the C-terminus of the GOI is a c-Myc tag for protein detection via Western blot.
Transcription of the GOI is terminated and transcripts are stabilized by the terminator and
3’ UTR of the white poplar chloroplast RuBisCo Large subunit (TrbcL), (Kolotilin et al.,
2013; Shinozaki et al., 1982). The candidate gene CPL was inserted into the vector
pLSCTGG using GoldenGate cloning (Figure 13B). To reveal potential detriments
caused by CPL expression, green fluorescence protein gene (GFP) was also inserted into
the GOI site in place of CPL using GoldenGate cloning (Figure 13C).
The vector pLSCTGG was modified such that the IEE was removed and the N. tabacum
psbA promoter was added in its place, with the intention of increasing aadA expression to
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confer strong spectinomycin resistance upon transformants. These modifications
generated a new vector, termed pLSCTGG-P (Figure 13D). A minimal vector, pHeri
(Figure 13E) was designed and assembled with the intention to avoid any unidentified
complications of other vectors that may affect transformation. This vector consists of
partial L. sativa chloroplast rubisco large chain (rbcL) and acetyl-coenzyme A
carboxylase subunit B (accD) gene sequences flanking the insert sequences to facilitate
recombination. Between the flanking sequences lies the N. tabacum ribosomal operon
promoter (Prrn), which drives expression of aadA. The aadA transcript is stabilized by
the L. sativa ribosomal protein S16 terminator (Trps16). No other elements were included
within the minimal vector, pHeri.

3.4.2

Procedural modifications conducted in attempts to generate
transplastomic L. sativa

As described in section 2.4.1.2, approaches used to generate transplastomic lettuce were
altered in many ways. Despite their demonstrated ability to regenerate on a media lacking
antibiotic selection of transformation, bombarded explants of L. sativa were generally
unable to regenerate shoots on selective media. However, in several occasions shoots
could be visualized regenerating from bombarded tissue that had begun to form callus.
These shoots were a lighter green colour than the original leaves from which they were
generated, and eventually lost all green colour to appear a yellow-brown-white. These
shoots would eventually die and appear to be viable only for a short time on selective
media. This was true for all except one occasion, when an antibiotic-resistant lettuce
callus grew on selective media, and maintained a light yellow-green colour following
transfer to new selective media. PCR was conducted to corroborate the transplastomy of
this callus. Following gel electrophoresis, no bands of the expected transplastomic size
could be produced using transplastomic gene-specific primers, as was successful for
transplastomic tobacco (described in section 3.5). Although transplastomic L. sativa
could not be produced, as a negative result this study may serve future researchers,
providing a record of procedures and modifications to those procedures that will not
produce transplastomic lettuce. The potential reasons for this outcome are explored in
section 4.4.
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3.5

Generation of transplastomic N. tabacum for

recombinant protein production
Transplastomic N. tabacum was generated as an alternate CPL production platform to
transplastomic L. sativa. Transplastomic N. tabacum has better-established chloroplast
transformation procedures, which allow chloroplast transformation where transformation
of L. sativa was unsuccessful. Transplastomic proteins have also been produced to
extremely high levels in N. tabacum chloroplasts, up to 70% TSP (Oey et al., 2009),
highlighting the potential for efficient protein production in N. tabacum. The candidate
vaccine protein produced transplastomically used native-encoded DNA sequences, fused
to a c-Myc tag for protein detection via Western blot. This gene was assembled using
GoldenGate technology and ligated into two previously-constructed chloroplast
expression cassettes (Kolotilin et al., 2013). These CECs (Figure 14) comprise many of
the same components as the first-designed L. sativa transformation vector (Figure 13A),
with a few key differences. Compared to L. sativa vectors, the N. tabacum CECs contain
shorter flanking sequences of trnI and trnA only, which are N. tabacum sequences rather
an L. sativa sequences. Similarly, the expression of the GOI is driven by the PpsbA of
N. tabacum (Verma et al., 2007) rather than that of L. sativa. The 5’ UTR of these CECs
also originates from N. tabacum psbA. The second cassette (Figure 14b), pCEC4, is
identical to pCEC5, but contains the downstream box from E. coli phage 7 gene 10
(T7g10) immediately upstream of the recombinant protein coding sequence. The
downstream box, nine amino acids translationally fused to the N-terminal end of the
recombinant protein, improves translation and protein stability (Kuroda et al., 2001).
Bombardment was conducted on N. tabacum cv. 81V9, a low alkaloid cultivar, using
pCEC5 and pCEC4 carrying the candidate vaccine gene. Use of the 81V9 cultivar
diminishes the levels of alkaloids that are undesirable in orally-administered vaccines
(Menassa et al., 2001). The initial transformation event does not transform all plastids or
genomes within a plant cell and thereby creates a heteroplasmic state, in which there are
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Figure 14. N. tabacum chloroplast transformation and expression constructs.
CPL was cloned into two pre-existing vectors. Each vector was used in minimally 25
bombardments. Nt trnI: N. tabacum transfer RNA isoleucine, IEE: intercistronic
expression element, aadA: aminoglycoside-3’ –adenyltransferase, TpsbC: terminator of
poplar photosystem II chlorophyll protein, Nt PpsbA: N. tabacum plastid promoter of
photosystem II protein D1, CPL: CTB-rPlpE-nLkt, c-Myc: tag for detection, TrcbL: 3’
UTR and terminator of the white poplar chloroplast RuBisCo Large chain gene. Nt trnA:
N. tabacum transfer RNA alanine.
A) pCEC5CPL: the first construct used for transformation, which was successful in
generating transformants. B) pCEC4CPL: the second construct used for transformation,
which was not successful in generating transformants. T7g10 5’+DB: E. coli phage 7
gene 10 5’ UTR and downstream box. Schematic is not to scale
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both transgenic and native plastids present within the first-transformed cell. To select for
transformed plastids, the antibiotic spectinomycin was applied within regeneration media.
Spectinomycin activity is detoxified by the AadA protein encoded within the
transformation cassette. As an adenyltransferase, the AadA protein confers
spectinomycin resistance by catalyzing the adenylation of a hydroxyl group of the
spectinomycin molecule (Wright, 1999). The selection process is necessary to ensure that
all plastids and all copies of the genome within each polyploid plastid are transgenic.
Following the selection process, carried out over three rounds of regeneration, the plant is
usually homoplasmic: all genomes within all plastids in all cells of the plant are identical,
and a stable transformant has been generated (Bock, 2015). Following regeneration,
transplastomic N. tabacum 81V9 plants grew successfully in soil in the greenhouse until
flowering and producing seeds. Seeds of self-pollinated plants were collected for storage
and growth of future plants of this strain.

3.5.1

Determination of homoplasmy in transplastomic lines

Homoplasmy in transplastomic lines precludes the loss of transgenes from the plastid
genome via genome segregation during plastid division, and maximizes transgene copy
number, thereby maximizing transgene expression and ultimately transgenic protein
accumulation (Bock, 2015). A Southern blot was therefore conducted to verify that
transplastomic plants were homoplasmic. A probe for this Southern blot was generated
previously (Kolotilin et al., 2012) and anneals within the N. tabacum trnI - trnA flanking
regions, facilitating binding of the probe to DNA from the pCEC5 vector carrying CPL
(pCEC5CPL), transplastomic genome sequences, and wild type genome sequences
(Figure 15A, B). In the Southern blot conducted by digesting total genomic DNA with
the restriction endonuclease RsrII and separating the digested DNA by agarose gel
electrophoresis (Figure 15C), all 5CPL plants were confirmed to be homoplasmic. Only
one band, of size 3502 bp, corresponding to the size of inserted DNA was detected in all
5CPL lanes and in the positive control consisting of pCEC5CPL plasmid (Figure 14A,
15B) used to transform N. tabacum plants. This suggests that 5CPL plants are
transplastomic, carrying the insert from the pCEC5CPL construct. The transplastomic
plants lack the smaller molecular weight band of 1054 bp, indicating that they lack wild
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Figure 15. Determination of homoplasmy in transplastomic lines.
A southern blot was conducted on seven transplastomic plants, one wild type negative
control, and the pCEC5CPL plasmid as a positive control.
A) A section of the wild type genome, showing the insertion site (arrow) of pCEC5 and
pCEC4 between trnI and trnA and the annealing location of the probe (horizontal bar).
The scissors indicate the digestion sites of the RsrII endonuclease. B) A section of the
transformed genome, with transplastomic sequences integrated between flanking
sequences as intended. C) A Southern blot conducted showing that transplastomic
tobacco lines are homoplasmic. The pCEC5CPL plasmid was used as a positive control
(+) to display the band size of transformed chloroplasts: 3502 bp. A wild type N. tabacum
plant was used as a negative control (WT), and displays a band of size: 1054 bp.
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type DNA. A larger molecular weight band is visible in the pCEC5CPL plasmid lanes as
a result of incomplete digestion of the pCEC5CPL plasmid, producing linearized plasmid
DNA with the flanking regions and plasmid backbone. The linearized plasmid has an
expected size of 7252 bp. Smaller bands are also present in plasmid lanes, which may
represent multiple conformations of supercoiled plasmid DNA, which flows through a gel
matrix faster than linear or circular forms, and may persist following incomplete
digestion.

3.5.2

Developmental dependence of recombinant protein
accumulation

To determine the most effective time to harvest N. tabacum leaves for processing prior to
vaccine delivery, CPL accumulation in leaves of multiple ages was compared (Figure
16A). This measurement may also provide information regarding the stability of CPL, as
more stable proteins will likely accumulate to higher levels in older leaves. Once a plant
had 10 leaves that were all at least 15 cm in length, they were sampled and proteins
extracted. A Western blot (Figure 16B) using an anti-c-Myc antibody was conducted to
reveal protein accumulation in the various leaves. Alongside the extracted plant proteins,
increasing known amounts of the eGEHK standard protein were loaded, and used to
calculate the accumulation of CPL in the leaves. Six independent transplastomic plants
were analyzed in this manner, and used as biological replicates. This experiment
demonstrated (Figure 16C) that CPL accumulates to the highest levels in the third, fourth,
fifth, sixth and seventh leaves. Of these leaves, the fifth leaf appears to have a nonsignificantly higher accumulation level than the other leaves. Specifically, CPL
accumulates to 17.1 ± 2.1 mg/kg (mean ± standard deviation of the mean) in the first leaf,
rises to 33.0 ± 2.7 mg/kg in the fifth leaf, and decreases gradually to 7.7 ± 0.9 mg/kg in
the tenth leaf. As with transiently expressed CPL (section 3.3.2), transplastomic CPL is
expected to accumulate as a 35.5 kDa molecule. The blot in Figure 16B shows bands of
roughly 35.5 kDa, 70 kDa, 140 kDa, and larger sizes. It is hypothesized that these bands
represent dimers, tetramers, and multimers of CPL. The lower 35.5 kDa band and the 70
kDa band were added to assess protein accumulation.
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Figure 16. Developmental dependence of protein accumulation.
A) A schematic of the N. tabacum plants, with leaves used for analysis numbered from
youngest (1) to oldest (10). B) A Western blot of proteins extracted from each of the 10
leaves sampled from one plant during this experiment, shown as a representation of the
six plants sampled. eGEHK: protein standard for quantification. C) The accumulation
level of CPL in each of the 10 leaves sampled. Six plants were sampled and considered in
this analysis. Error bars represent standard error of the mean. Means that are not labelled
with the same letter are significantly different. Means were compared using ANOVA
followed by Games-Howell pairwise comparisons.

66

3.5.3

Quantification of recombinant protein accumulation

CPL was quantified in transplastomic lines to assess whether the lines could produce
commercially viable levels of this protein. To assess accumulation within the entirety of
each plant, quantifications from the developmental dependence experiment were used.
The protein levels in each leaf were averaged to estimate the average protein level within
a single plant. This protein level was averaged across six plants to reveal that the
recombinant protein accumulates to an average of 23.0 ± 5.6 mg/kg FW (Figure 17).
Analysis of sequentially-extracted soluble and insoluble proteins from the same tissue
revealed that the protein accumulates mainly as an insoluble form, accumulating to 7.4 ±
3.8 mg/kg FW as a soluble form, and 15.6 ± 4.6 mg/kg FW as an insoluble form.

3.5.4

Developmental effects of transplastomic recombinant protein

To accurately assess the phenotypic effects of the genotypic changes implemented in this
study, the development of transplastomic N. tabacum was monitored (Figure 18).
Measurements of plant height, the length and width of the largest two leaves present, the
total number of leaves longer than 2 cm, and of flowering time demonstrated that
transplastomic plants carrying CPL had significantly reduced growth and flowered and
produced seeds after a longer period of time (Figure 19). It is visibly noticeable (although
less obvious in print) that the transplastomic plants generated are of a lighter shade of
green than wild type plants (Figure 19). While transplastomic plants grow slower in terms
of height, and reach flowering stage later (Figure 19A), neither the size of the largest
leaves nor the number of leaves appears to be affected (Figure 19B, C, D, E). The time to
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Figure 17. Quantification of recombinant protein accumulation in transplastomic
N. tabacum.
The average accumulation levels in N. tabacum was determined by averaging the protein
accumulation levels each of 10 sampled leaves, and averaging these levels across the six
sampled plants. Error bars represent standard error of the mean of plants. Bars that are
not labelled with the same letter are significantly different.
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Figure 18. Visualization of developmental effects of CPL expression from the
chloroplast genome.
Transplastomic CPL plants grown alongside wild type plants under identical growth
conditions display differences in phenotype, including height and leaf color.
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Figure 19. Developmental effects of CPL expression from the chloroplast genome.
Seven transplastomic plants and five wild type plants were utilized in this experiment. All
error bars represent standard error of the mean. Stars are placed above data points to
indicate significant difference between the 5CPL and wild type group at that point in
time. A) Height and flowering time. B) Average length of longest two leaves. C) Average
width of longest two leaves. D) Average leaf area of longest two leaves, modelled as
ellipses. E) Number of non-chlorotic leaves arising from main stem.
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reach a height of 80 cm significantly differed between transgenic and wild type plants,
with transplastomic plants reaching 80 cm at 8 ± 0.45 weeks, and wild type plants at only
5 weeks, with all plants flowering within the same week (Figure 19A). Flowering time
was the most affected variable measured, with transplastomic plants flowering at 8.3
weeks after transplanting, and wild type plants at only 5 weeks. This difference was
statistically significant. The transplastomic plants produced seeds that appear
indistinguishable from wild type seeds and are therefore presumed to be fertile, although
this has not yet been verified experimentally.

3.5.5

Recombinant protein accumulation in fresh and lyophilized
N. tabacum leaf tissue

To determine whether CPL can survive lyophilization, which is generally implemented
for tissue storage prior to vaccine delivery, transplastomic N. tabacum leaf tissue was
lyophilized. One leaf was collected from four different plants, and protein accumulation
was measured before and after lyophilization. For this, total protein was extracted from
each lyophilized and frozen tissue and quantified using Western blot. This test revealed
that CPL persists at 46.9 ±10.3% of its original level following lyophilization (Figure
20A), constituting an average of 48.0 ± 21.7 mg/kg DW, up to 84 mg/kg DW in the
leaves sampled. Comparatively, CPL accumulated to an average of 18.7 ± 9.9 mg/kg FW
in the unlyophilized tissue sampled. The CPL protein appears to persist in an intact form
of size equal to that of CPL extracted from non-lyophilized tissue. No degradation
products were visible on Western blots conducted with extracts from lyophilized tissue
(Figure 20B).
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Figure 20. Recombinant protein accumulation in fresh and lyophilized N. tabacum
leaf tissue.
A) Recombinant protein accumulation in four leaves collected from four separate plants,
and an average of the recombinant protein accumulation those four leaves in each fresh
and lyophilized tissues. Values for fresh tissue are calculated per fresh weight, while
values for lyophilized tissue are calculated per dry weight. B) Western blot showing
recombinant protein accumulation in each of the four sampled transplastomic leaves,
alongside a wild type negative control. eGEHK is a protein standard used for
quantification.
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Discussion
4.1

M. haemolytica vaccine design

Multiple vaccines against M. haemolytica infection have been developed, originally
composed of cell culture supernatants or killed M. haemolytica. More recent efforts have
focused on transgenically-produced M. haemolytica antigens as vaccines, delivered either
subcutaneously or nasally (Ayalew et al., 2008; 2009; Confer et al., 2009a; 2009b). These
vaccines are composed of two M. haemolytica proteins: Pasteurella lipoprotein E (PlpE)
and leukotoxin (Lkt). PlpE is a surface lipoprotein of M. haemolytica. Antibodies against
PlpE facilitate complement-mediated bacteriolysis and phagocytosis of the bacterium
(Ayalew et al., 2008). Lkt is a secreted toxic molecule that binds to the LFA-1 receptor of
leukocytes (Atapattu et al., 2005), leading to caspase 9-dependent apoptosis and
ultimately inflammation and damage to alveolar tissues (Zecchinon et al., 2005).
Inclusion of Lkt epitopes in vaccines has been demonstrated to be highly beneficial but
not sufficient for robust protection against M. haemolytica infection (Conlon et al.,
1991b). One effective vaccine against M. haemolytica was therefore designed as a
recombinant protein comprising neutralizing and immunogenic epitopes of Lkt and plpE,
specifically the neutralizing epitope of Lkt: nLkt, and the r2 region of plpE: rPlpE.
Efficacy of nasally-administered M. haemolytica vaccines has been improved through the
addition of a protein subunit originating from V. cholerae, CTB (Confer et al., 2009b).
This improvement is strengthened by linking the CTB protein directly to the vaccine
(Ayalew et al., 2009). CTB forms a pentamer which binds the GM1 ganglioside and
triggers uptake of the subunit into epithelial cells (Spangler, 1992). CTB acts as a strong
mucosal adjuvant and also presumably facilitates uptake of translationally-fused
recombinant protein into epithelial cells and later recognition and response by the
immune system, leading to the general improvement in efficacy of vaccines linked to
CTB (Holmgren et al., 2005; Sheoran et al., 2002). This vaccine, designed and tested by
Confer, Ayalew et al. (2009b), appears in the literature to be the most effective subunit
vaccine developed thus far. The major goal of this study was to produce a similar vaccine
in plant tissue for oral delivery to cattle.
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4.2

Transient production of CPL in L. sativa

The CPL protein accumulated to detectable levels in L. sativa only when targeted to the
chloroplast and extracted using an insoluble protein extraction buffer. Differences in
protein accumulation are expected across cellular compartments, as each compartment
has different biochemical composition and protease content (Pillay et al., 2014;
Streatfield, 2007). Accumulation in L. sativa was accomplished after some improvement
of infiltration techniques, and by the same infiltration technique on the same day that led
to high accumulation levels in N. benthamiana. The cause of these low accumulation
levels is not known. It is presumed that errors in infiltration would be minimal as the
same infiltration technique, used on the same occasion, led to high accumulation levels in
N. benthamiana. One potential explanation for low accumulation levels in L. sativa is
poor infection by A. tumefaciens. It is notable that infiltration techniques, while adjusted
for L. sativa expression based on available literature, have been optimized for
N. benthamiana expression, with L. sativa receiving significantly less attention in the
literature and no previous testing in our lab. The OD used in this infiltration was 0.7, a
compromise of ODs employed by others in the literature (Chen et al., 2016; Joh et al.,
2005; Li et al., 2007a; Negrouk et al., 2005; Wroblewski et al., 2005).
A. tumefaciens strain may also play a role in infection success, and should therefore be
considered (Li et al., 2007a). While the EHA105 strain employed in this study has been
confirmed to successfully infect L. sativa (Lupan et al., 2010; Zhao et al., 2017), it is
uncommon for this purpose, and the efficiency of L. sativa infection by agrobacterium
EHA105 strain is not known. Two other laboratory strains, GV3101 and C58C1,
predominate in literature regarding transient protein expression in L. sativa (Chen et al.,
2016; Joh et al., 2005; Li et al., 2007a; Negrouk et al., 2005; Wroblewski et al., 2005).
The C58C1 strain has been demonstrated to infect an average of 80% of cells in one
study (Wroblewski et al., 2005), and the GV3101 strain produced 50 mg/kg FW of
antibody protein in another study, confirming that these two strains are sufficiently
capable of lettuce cell infection. It is therefore possible that A. tumefaciens strain could be
responsible for low accumulation levels, with L. sativa possessing some degree of
resistance, or poor amenability to infection by A. tumefaciens EHA105. This has been
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observed for other strains, which infect N. benthamiana but not L. sativa (Wroblewski et
al., 2005). This would be most easily tested by comparing protein accumulation between
plants or leaves infiltrated with the three different strains carrying identical constructs.
Another explanation is that transient expression from the delivered plasmid was
insufficient. This could be explored using quantitative real-time PCR (qRT-PCR) to
analyze foreign transcript levels. However, it is expected that expression from the doubleenhanced CaMV 35S promoter should be sufficient for protein accumulation, as this
promoter has routinely been used to drive relatively high-level expression of transientlyproduced proteins in L. sativa (Joh et al., 2005; Li et al., 2007a; Liu Clarke et al., 2017;
Negrouk et al., 2005; Sohi et al., 2005; Wroblewski et al., 2005). The 35S promoter is
also exceedingly the most common promoter employed in transient expression in lettuce
(Dong et al., 2014). Another promoter occasionally used in place of 35S is the ubiquitin
promoter (Dong et al., 2014). In one study wherein a taste-modifying protein, miraculin,
was produced in lettuce, the ubiquitin promoter and terminator were compared to the 35S
promoter and NOS terminator. It was demonstrated by qRT-PCR and Western blot that
the miraculin RNA and protein respectively were present at higher levels under the
ubiquitin promoter and terminator than 35S and NOS (Hirai et al., 2011). Another study,
in which CTB was produced by nuclear transformation and expressed from the ubiquitin
promoter and terminator, found the CTB gene to be expressed and the protein to
accumulate to 0.24% TSP. While this constitutes a successful employment of the
ubiquitin promoter, it was not compared with the 35S promoter, and therefore no definite
conclusions can be made. If low transcript levels in infected cells could be identified, use
of the ubiquitin terminator may serve as a potential solution.
It is not expected that inefficient translation from produced transcripts led to low
accumulation, as these genes were optimized for expression from the lettuce nucleus and
should therefore be translated efficiently. However, it is possible that the optimization
was misinformed and sequences used are not necessarily those best suited for rapid
translation. While codon optimization follows trends in codon usage bias of the target
genome, translational efficiency is not consistently correlated with codon usage.
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Similarly-frequent codons can exhibit large differences in translational efficiency
(Nakamura et al., 2011).
While CPL is surely less stable than GFP, which accumulated to detectable levels in both
the chloroplast and ER of lettuce, the protein is sufficiently stable to accumulate to levels
as high as 200 mg/kg in N. benthamiana. However, these two plants are not closely
related and therefore a protein may be stable within the cells of N. benthamiana but not
those of L. sativa. While infection efficiency is similarly high in L. sativa compared to
N. benthamiana using A. tumefaciens C58C1 (Wroblewski et al., 2005), accumulation
levels of the same protein in the two species are not well-known. This study may
therefore serve as one of the first comparisons of protein stability within the two species.

4.3

Transient production of CPL in N. benthamiana

The CPL protein accumulated in N. benthamiana to levels significantly higher than those
observed in L. sativa. The protein accumulated to high levels in both the chloroplasts and
the ER, with accumulation in the ER somewhat higher, albeit not significantly, than
within the chloroplasts. This trend could be attributed to the suite of chaperones available
within the ER, its low hydrolytic activity, or its oxidizing environment (Vitale et al.,
2005). For its general amenability to foreign protein accumulation, many recombinant
proteins have been produced to high levels through targeting to the ER (Vitale et al.,
2005). While CPL accumulates to high levels within the ER, the ER-targeted CPL protein
appears to be modified, as it shows a larger size than expected when assayed via Western
blot. Since a similar protein produced transiently in our lab, comprising a larger region of
PlpE than produced in this project, was shown to be glycosylated, it was expected that
CPL may be glycosylated, leading to molecular weight increases. Additionally, the CTB
protein has been demonstrated to be glycosylated following plant nuclear expression
(Matoba, 2015). This encoded glycosylation site was not removed from CPL as the
glycosylation was found not to affect immunogenicity in an animal model (Matoba,
2015). A glycan side chain would therefore be expected to be present on ER-targeted
CPL, although the identified glycan common in plant-produced CTB is only 3 kDa in
size (Mishra et al., 2006), much smaller than the increase in size of CPL observed here.
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Speculating that glycosylation may be responsible for observed size increases, a deglycosylation assay was conducted. The results of a de-glycosylation assay suggested that
the soluble form of CPL within the ER is not glycosylated. However, this result was not
conclusive as banding was faint for de-glycosylated CPL extracts, and not especially
clear for a positive control. It is therefore unknown what post-translational modifications
(PTMs) might have led to this increase in molecular weight. There exists a multitude of
different post-translational modifications that could lead to this size increase (Friso et al.,
2015). One potential modification that is sufficiently large to cause the size change
observed is the addition of a small ubiquitin-like modifier, or SUMOylation.
SUMOylation entails the binding of an approximately 12 kDa protein to the lysine
residues of the target (Friso et al., 2015). The observed size increase in the ER is roughly
12 kDa, and CPL contains four potential SUMOylation motifs (Zhao et al., 2014),
making SUMOylation a potential cause of this increase. There is some potential that posttranslational modifications to proteins targeted to the ER could interfere with vaccine
epitope exposure. Therefore, ER-targeting is not preferred, especially if accumulation is
sufficiently high when targeting to other compartments.
The CPL protein was also targeted to the chloroplast, first as a potential production
method, and secondly as a representation of accumulation levels in transplastomic
N. tabacum. The CPL protein is stable within the chloroplasts, albeit at somewhat lower
levels than within the ER. The chloroplast-targeted CPL protein accumulated mainly as
an insoluble form, which appeared to contain no significant PTMs, as it is of the expected
molecular size, 35 kDa. However, the soluble form, similar to ER-targeted CPL,
comprises both 35 kDa molecules and larger molecules similar in size to those of ERtargeted CPL. The origin of this size increase is unknown. Proteins must be trafficked
along the secretory pathway to undergo glycosylation (Friso et al., 2015), and therefore
this is not a possibility. It is assumed that the rubisco transit peptide used for trafficking
to the chloroplast is cleaved off after CPL reaches its destination. However, it may be
possible that the transit peptide is not cleaved properly, and remains attached to CPL. The
rubisco transit peptide used in this study is approximately 6 kDa in size and could
therefore explain the size increase observed. It is notable that the modification of CPL
observed in the chloroplast is associated with solubility: Roughly half the molecules of
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the soluble form are modified, while those of the insoluble form are not. Modifications
may therefore be involved in improving solubility or are perhaps only possible for
soluble molecules, with insoluble ones inaccessible to post-translationally-modifying
enzymes.
It is hypothesized that proteins expressed from the nucleus that accumulate well when
transported into the chloroplasts will also accumulate well when produced within the
chloroplasts, as accumulation is largely dependent upon the stability of each protein in its
subcellular location (Bock, 2015). This trend has been observed for proteins such as a
fimbrial protein from enterotoxic E. coli, FaeG and a xylanase from Aspergillus niger
(Kolotilin et al., 2012; Kolotilin et al., 2013). It was therefore expected that CPL
accumulation levels within transplastomic N. tabacum would be quite high.
Transplastomic production also requires neither A. tumefaciens culturing nor infiltration
procedures, which are intensive and expensive. For these reasons, along with the
aforementioned lack of PTMs on chloroplast-produced proteins, I attempted to produce
CPL in lettuce and tobacco chloroplasts an alternative production platform to transient
expression.

4.4

Attempts to generate transplastomic L. sativa

To generate transplastomic L. sativa, a straightforward protocol was attempted, which
was demonstrated to be successful in producing transplastomic tobacco (Kolotilin et al.,
2012). Many modifications to this protocol were gleaned from published studies that
reported successful transformation of L. sativa chloroplasts. The cultivar Simpson Elite
was acquired as one group has shown repeated success in transforming and generating
this cultivar (Boyhan et al., 2011; Kanagaraj et al., 2011; Ruhlman et al., 2007; Su et al.,
2015). Regeneration experiments were conducted to disprove the hypothesis that
chloroplasts may be transformed but unable to multiply within plant tissue that does not
regenerate. These experiments also served to optimize regeneration conditions. The
optimized hormone concentration for shoot proliferation of 0.2 mg/L BAP and 0.1 mg/L
NAA was used for regeneration of all bombarded explants, the majority of which
originated from the Simpson elite cultivar.
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I hypothesized that perhaps CPL itself was produced within transformed chloroplasts, but
imposed such detriments on transformed chloroplasts that they could not survive. It has
been demonstrated that some proteins confer significant negative health effects on plants,
specifically chloroplasts (Lentz et al., 2012). This causes the resulting transplastomic
plants to be a lighter green colour and to grow slowly (Kolotilin et al., 2013; Miletic et
al., 2017). Indeed, this effect was observed in N. tabacum expressing the recombinant
protein in this study. To disprove this hypothesis, GFP was used. GFP is known to be
innocuous and to express well in many biological systems, including plant chloroplasts.
Therefore, GFP was cloned into the L. sativa chloroplast transformation construct in
place of CPL. This construct was used in 65 bombardments and did not yield any
transformants.
There exist multiple reports of L. sativa chloroplast transformation with physical
conditions of transformation often differing between reports. In attempts to generate
transformants, variables that differed between reported transformations were altered and
tested at each possible configuration. These include leaf orientation, which is adaxial side
upward in many successful reports (Boyhan et al., 2011; Harada et al., 2014; Kanagaraj et
al., 2011; Kanamoto et al., 2006; Lim et al., 2011; Maldaner et al., 2013; Ruhlman et al.,
2007; Su et al., 2015), but abaxial side upward in N. tabacum transformation (Boyhan et
al., 2011; Kolotilin et al., 2012; Kolotilin et al., 2013; Ruhlman et al., 2007). Target
distance, the distance between the leaves and the macrocarrier, through which the gold
particles travel, also varies between reports, with some using 6 cm (Ruhlman et al., 2007)
and others 9 cm (Lim et al., 2011; Tabar et al., 2013). Both of these distances were
employed in bombardments. Other possible distances, 3 cm and 12 cm were also used.
Leaves were also stacked on top of one-another in another trial as it was hypothesized
gold may travel through the first leaf and penetrate into the chloroplasts of the second or
third. Another protocol similar to that of the Menassa lab was acquired by request from
another lab attempting produce transplastomic L. sativa. This protocol recommended
beginning leaf regeneration one day prior to conducting the transformation procedure,
cutting leaves prior to bombardment, and using a 0.1 mg/L BAP, 0.1 mg/L NAA
regeneration medium. This protocol was precisely followed, although notably this
regeneration medium is sub-optimal for all of the cultivars used in this study.
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I then hypothesized that transcription of the aadA gene in the original chloroplast
transformation construct may be insufficient to confer strong spectinomycin resistance.
The original chloroplast transformation construct relied upon read-through transcription
from the rRNA operon, which begins upstream of the trnI - trnA insertion location. While
this locus offers sufficient transcription for inserted aadA in N. tabacum to confer
spectinomycin resistance, it is unknown whether the same is true for L. sativa. To test this
hypothesis, the promoter from N. tabacum psbA was inserted immediately upstream of
the aadA gene in efforts of improving transcription. Additionally, explants were
regenerated on media containing 30 mg/L spectinomycin rather than 50 mg/L. These
modifications did not yield any transformants either.
After extensive modifications to procedure and constructs, I hypothesized that an error in
the design of the pLSCTGG construct may have produced a flaw, present in all
subsequent constructs, which abrogated L sativa chloroplast transformation. To refute
this hypothesis, a minimal construct for L. sativa chloroplast transformation was
assembled, which comprised rbcL and accD flanking sequences. Between flanking
sequences, a N. tabacum rrn promoter drives aadA expression and the L. sativa rps16
terminator and 3’UTR halt transcription and stabilize the aadA transcript. No unnecessary
genes or associated genetic elements were included in this construct to reduce the
possibility that any component may interfere with transformation or proliferation of
transformed chloroplasts. This construct did not produce any transplastomic lettuce
either.
It is also notable that although a N. tabacum transformant was identified for the pCEC5,
transformation efficiency for N. tabacum in this study is still far below expectations
(Ruhlman et al., 2010). It was therefore hypothesized that transformation efficiency for
L. sativa may be excessively low, such that transformation is possible but unlikely. The
total number of bombardments used to generate one N. tabacum transformant in this
study using the pCEC5 construct was 40. Comparatively, over 200 bombardments were
conducted on L. sativa and no transformants could be identified, despite regenerability. It
is therefore possible that an unidentified factor reduced transformation efficiency in both
cases. This reduction could have compounded with the lowered transformation efficiency
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of L. sativa, which is not optimized in our lab, to reduce efficiency to levels too low for a
transformation event to be likely within 200 bombardments.

4.5

Generation of transplastomic N. tabacum

One transplastomic N. tabacum line expressing CPL was produced. Transformation
efficiency was low, and therefore no pCEC4 transformants were generated. Only one
transformant was generated using a similar construct, pCEC5, and this transformant was
regenerated into seven clones. Southern blots demonstrated that these clones were
homoplasmic. Despite homoplasmy, the recombinant protein did not accumulate to
exceptionally high levels in any of the clones. This is not uncommon, as accumulation of
different proteins often varies despite expression from identical constructs. The low level
of protein produced is best described relative to other transplastomically-produced
proteins. For instance, EspA, a protein from shiga-toxin producing E. coli produced using
this same expression cassette accumulated to 220.7 mg/kg of dried leaf tissue, although
two other genes in the same construct did not produce any detectable level of protein
(Miletic et al., 2017). A xylanase produced using the same expression cassette
accumulated to much higher levels: 1.3 g / kg (Kolotilin et al., 2013) and FaeG
accumulated to 2.0 g / kg leaf tissue. There is evidently a large degree of variation
between the accumulation levels of different proteins produced transplastomically (Bock,
2014a), and it is therefore important to consider the causes of these differences to develop
potential strategies to increase protein accumulation levels.
Transcript levels, influenced by both transcription rates and RNA stability, could
ultimately affect protein accumulation. In one report wherein the enzyme lycopene Bcyclase was expressed within transplastomic tomato, RNA transcript levels were found to
be excessively low, leading to low protein accumulation levels (Wurbs et al., 2007). As
conducted in that study, qRT-PCR could be employed to assess RNA levels within the
tissue of transplastomic N. tabacum plants generated in this study. It is notable that three
studies have demonstrated variable protein accumulation levels while expressing
different genes using the pCEC5 vector (Kolotilin et al., 2012; Kolotilin et al., 2013;
Miletic et al., 2017).
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Another factor affecting transgenic protein levels is translational efficiency. As with all
organisms, chloroplasts display biases towards using certain codons over others. Codons
that are less common tend to result in lower foreign protein yields (Gustafsson et al.,
2004). In one study, accumulation of the human growth factor B3 was demonstrated to
increase 75-fold in N. tabacum chloroplasts following codon-optimization of the
sequence (Gisby et al., 2011). However, it is notable that this difference resulted from
altering codon usage from that of a mammal to that of a chloroplast, two organisms that
are only distantly related. Conversely, in this study prokaryotic genes were transformed
into chloroplasts, both of which have prokaryotic codon usage, which could be expected
to exhibit higher similarity to each other than to animals. Therefore, in this study, codon
usage of the recombinant candidate vaccine gene was not modified when producing
transplastomic constructs, which were intended for expression by both L. sativa and
N. tabacum. As detailed previously, there is also evidence that the codon usage bias of an
organism may not necessarily correlate directly to translational efficiency (Nakamura et
al., 2011). It may therefore be possible that current codon-optimization schemes do not
necessarily lead to increases in protein levels, especially when genes are transferred
between related species.
Protein stability is likely the largest contributor to foreign protein accumulation levels
within chloroplasts (Bock, 2015). The chloroplast genome encodes 11 or more protease
families, which are mainly of bacterial origin (Sakamoto, 2006). These proteases function
to eliminate proteins that have been overproduced, or display an incorrect shape due to
errors in synthesis, folding, or damage thereafter. Unstable proteins are more likely to
misfold, potentially forming aggregates, and triggering degradation by native proteases. It
is therefore paramount that designed recombinant proteins are as stable as possible to
avoid protein degradation. One of the primary factors affecting the half-life of proteins
within cells is the sequence of amino acids found at the N-terminus of the protein. This
correlation, termed the N-end rule, applies to prokaryotes and eukaryotes alike
(Varshavsky, 1996), and not surprisingly, seems to apply to chloroplasts as well (Apel et
al., 2010). It was concluded that in chloroplasts of N. tabacum, the second residue in a
protein sequence had a great impact on protein accumulation. This effect was most
pronounced when the second amino acid was changed to glutamic acid, and therefore
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glutamic acid was included as the second amino acid in the L. sativa expression
constructs designed in this study. Researchers have also observed increases in protein
accumulation after translationally fusing foreign proteins to the N-terminus of GFP,
suggesting other determinants of protein stability also seem to be found elsewhere within
the N-terminal region of proteins (Apel et al., 2010). Similarly, the HIV protein
cyanovirin-N, was not detectable in transplastomic tissue when transformed alone, but
accumulated to detectable levels when GFP was fused to the N-terminus. In this case,
mRNA stability was also observed to increase following this fusion (Elghabi et al., 2011).
It might therefore be predicted that the recombinant protein produced in this study could
be stabilized by CTB, which has accumulated to high levels as a component of other
recombinant proteins (Davoodi-Semiromi et al., 2010; Ruhlman et al., 2007).
Accumulation levels of transiently-produced proteins targeted to the chloroplasts can
serve as a prediction of transplastomic accumulation levels. When the gene for an ERaccumulating storage protein from maize was expressed transplastomic N. tabacum, it did
not accumulate to detectable levels within the chloroplasts (Bellucci et al., 2005). The
storage protein also did not accumulate when produced through nuclear transformation
and targeted to the chloroplast, although transcript levels appeared reasonable by
Northern blot. It was therefore concluded that accumulation defects were due to protein
instability within chloroplasts. The converse situation was demonstrated by the
aforementioned expression of FaeG and a xylanase, both of which accumulated to high
levels within the chloroplasts following infiltration, and in transplastomic plants
(Kolotilin et al., 2012; Kolotilin et al., 2013). By this logic it is mysterious that
accumulation levels of transiently produced CPL in this study were comparable between
the ER and chloroplast targeted proteins at 235 mg/kg FW and 163 mg/kg FW
respectively, although far less protein accumulated in transplastomic CPL-expressing
plants, averaging 23 mg/kg FW.
A final factor affecting the level of detected recombinant protein, but not accumulation
levels, is the extraction buffer used. In this project, two extraction buffers were employed
to assess the amount of soluble and insoluble protein. It was revealed that roughly onethird of the CPL accumulated in soluble form and two-thirds in an insoluble form. The
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insoluble form of CPL forms multimers, as demonstrated by western blot in Figure 15B.
These multimers are likely caused by association of multiple CTB subunits, which form
pentamers in their native form (Spangler, 1992). Since CTB interacts with its target
receptor as a pentamer (Spangler, 1992), it is beneficial that CTB exists in multimeric
forms, although it is not known whether insoluble multimers would be liberated during
digestion and regurgitation in ruminants from the membranes they seem to bind.

4.6

Transplastomic CPL as a vaccine against

M. haemolytica
In this project, a candidate vaccine against BRD was designed and produced to an
appreciable level. While other proteins have accumulated to considerably higher levels
than CPL, it is notable that such high accumulation levels are not invariably necessary for
use of plant material as an oral vaccine. For example, both IgA and IgG responses were
triggered in pigs orally administered 50 grams of fresh N. tabacum leaf tissue containing
0.11 mg/kg fresh leaf weight of vaccine comprising the porcine reproductive and
respiratory syndrome virus envelope glycoprotein 5 (Chia et al., 2010). Similarly, in
another study, an immune response could be produced by feeding mice tobacco tissue
containing a subunit vaccine comprising antigens of Crimean-Congo Hemorrhagic Fever
Virus, which accumulated to only 1.8 mg/kg of fresh leaf tissue (Ghiasi et al., 2011). In
addition, another study demonstrated that tobacco-produced LTB could induce immune
responses in mice after orally administering fresh tissue that contained only 0.0014%
TSP of LTB (Ghiasi et al., 2011). The demonstrated success of low-accumulating
transgenic plants as oral vaccines suggests it may be possible to produce an oral vaccine
from tissue of N. tabacum generated in this study.
It is also useful to consider how much candidate vaccine protein total should be
administered when speculating on the necessary accumulation levels and therefore
amount of administered leaf tissue. In the study that demonstrated efficacy of the subunits
produced in this project, 112 µg of a similarly-designed vaccine was administered nasally
to calves. This led to significant IgA responses against whole cells and Lkt, and the
vaccine offered protection against M. haemolytica bacteria (Ayalew et al., 2009). In
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comparison, to administer 112 μg of the vaccine produced in this study would require
only 5 g of lyophilized plant tissue. It is of course expected that significantly less of the
recombinant protein would reach immune cells than if a purified protein were
administered. However, it would be substantially less intensive to deliver leaf tissue than
purified protein, despite the significantly higher dose necessary. As opposed to nasal
delivery, oral delivery poses the risk of antigen degradation within the ruminant digestive
tract. The recombinant protein must remain intact for some period within the rumen to be
exposed to tonsillar and nasal mucosae upon regurgitation (Shewen et al., 2009). It is not
known to what extent the protein produced is stable within the rumen environment, and
therefore it is difficult to predict how much plant tissue is required for an effective dose
of vaccine.
To identify an effective dose of the CPL candidate vaccine and to determine whether
CPL is efficacious as a vaccine when administered in this manner, a feeding trial must be
conducted. While not the ultimate goal of this work is to administer CPL to cattle, oral
immunogenicity could be first tested in small mammals such as mice or rabbits. In such
an experiment, the recipient animal would be tested for neutralizing antibodies against
M. haemolytica and the leukotoxin. In one study, wherein a GFP-Lkt fusion vaccine was
produced in white clover, it was demonstrated that rabbits that had been injected with a
protein extract developed antibodies capable of neutralizing native Lkt molecules (Lee et
al., 2001). The same group produced a 50 kDa truncated form of Lkt in alfalfa, termed
Lkt50, and challenged calves with M. haemolytica infection following immunization with
their vaccine. The vaccinated calves possessed anti-Lkt IgG and IgA antibodies before
challenge with M. haemolytica, rising significantly in titer following challenge,
conferring strong resistance against the pathogen. Calves that did not receive the vaccine
developed lower titers of anti-Lkt antibodies following challenge, and were severely
affected by the disease. In that study, calves were fed 300 g of dried plant tissue each day
for five days, and this was repeated two weeks later. With accumulation levels of roughly
90 mg/kg DW, calves received 27 mg of vaccine protein per day, a total of 270 mg over
the ten feeding days (Shewen et al., 2009). Comparably, CPL accumulated at up to
84 mg/kg DW in transplastomic tobacco, and therefore a slightly larger dose of 322 g
DW per day would be required to achieve the same vaccine dose. It is also worth noting
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that Lkt50 contains only the Lkt protein, whereas the CPL vaccine produced in this
project contains epitopes of CTB, PlpE, and Lkt. The inclusion of CTB is expected to
boost immunogenicity, while PlpE epitopes are expected to facilitate destruction of the
bacteria. At a molecular weight of only 35 kDa, compared to the 50 kDa of Lkt50, the
CPL candidate vaccine would also provide more vaccine molecules if a comparable
weight of protein were delivered. One might therefore hypothesize that the CPL vaccine
would be more efficacious and require a lower dose than this alfalfa-produced vaccine.
To corroborate this hypothesis would necessitate animal trials.
Since animal trials with large animals such as calves are expensive, it would be judicious
to first conduct such a trial with a smaller mammal model, as has been performed for
another M. haemolytica vaccine. The M. haemolytica surface protein Gs60 produced in
transgenic alfalfa was administered to rabbits both orally and via injection. Both
administration methods triggered immune responses and the production of anti-Gs60
antibodies that recognized genuine Gs60 in extracts of M. haemolytica (Lee et al., 2001).
It is likely that vaccines that are immunogenic and elicit antibody production in small
mammal models could evoke similar responses in calves, considering that calves
ruminate, and repeatedly pass antigens over the mucosal tissues of the tonsils and
adenoids (Shewen et al., 2009). Therefore, following positive results in small mammals,
CPL could later be used in a challenge experiment, wherein it would be orally
administered to calves, followed by challenge with M. haemolytica. While experiments
such as these have been performed with a highly similar vaccine following purification
from bacteria (Ayalew et al., 2009), and a less-similar vaccine produced in alfalfa
(Shewen et al., 2009), and shown promising results, this would be the first animal test of
this antigen combination produced in plants.
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Conclusion and future perspectives
In this project, I ultimately intended to generate a plant-based production system for a
vaccine against M. haemolytica. In this respect, the project was certainly successful, as
protein production appears to rival that of other labs producing similar vaccines that have
progressed to animal trials. However, the specific objectives of this study must be
addressed. While a considerable amount of effort was directed toward developing
transgenic L. sativa as a production platform, transplastomic L. sativa could not be
generated, and little accumulation of foreign protein was observed. I have speculated on
the potential causes of these issues, making them extremely difficult to overcome. It is
unfortunate that the extensive optimization of L. sativa growth and regeneration in our
lab therefore cannot be applied. Optimistically, it is possible that future efforts to
transform L. sativa chloroplasts or to transiently produce proteins will be more
successful, allowing application of the optimizations conducted here.
Similar to much of the work in this thesis, the future performance of the CPL candidate
vaccine is unpredictable. It is not known whether CPL will survive the rumen
environment in a sufficient extent to deliver antigens to immune cells. If CPL is
sufficiently stable, it must also provoke an effective immune response to function as a
vaccine. This will likely require liberation of insoluble CPL, which may or may not occur
within the rumen. These uncertainties can only be addressed through continued
experimental analysis.
While CPL accumulated in transplastomic N. tabacum to levels comparable to those of
another lab, it is not known whether these levels will be feasible for commercial
production of CPL as a vaccine. The field of plant biotechnology is still relatively young,
with chloroplast biotechnology specifically much smaller and younger. While protein
production in transgenic plants, and particularly within chloroplasts, has proven
extremely effective and adaptable (Ahmad et al., 2010), there is still much to be learned.
However, chloroplast biotechnology is advancing quickly, and it is hoped that incoming
knowledge from new research will contribute to the production of biologically important
proteins such as CPL produced in this study. Through thoughtful integration and
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application of knowledge of plant biotechnology and immunology, it is my hope that in
the near future bovine respiratory disease, the devastating outcome of M. haemolytica
infection can be restrained.
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